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LIST OF TRIVIAL NAMES AND ENZY~£S 
Trivial names used in this 
work 
cholesterol 
epi-cholesterol 
20a-OH cholesterol 
22R-OH cholesterol 
20a,22R-di-OH cholesterol 
20a,22S-di-OH cholesterol 
17a,20a-di-OH cholesterol 
~ 20 - 22 cholesterol 
~ 17 - 20 cholesterol 
20,22-epoxy cholesterol 
corticosterone 
cyanoketone 
deoxycorticosterone 
dehydroepiandrosterone 
20a-hydroperoxycholesterol 
flavoprotein (adrenodoxin 
reductase) 
glucose-6-phosphate dehydro-
genase 
steroid liS-hydroxylase 
steroid !?a-hydroxylase 
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Systematic names 
- 5-cholesten-3S-ol 
- 5-cholesten-3a-ol 
- (20S)-5-cholesten-3B,2D-dio1 
- (22R)-5-cholesten-3S,22-dio1 
- (20R,22R)-5-cholesten-38-20, 
22-triol 
- (20R,22S)-5-cholesten-38,20, 
22-triol 
- (17S,20S)-5-cholesten-3S,l7, 
20-triol 
- 5,20(22)-cholestadien-3S-ol 
- 5,17(20)-cholestadien-38-ol 
- (20<,22<)-20,22-epoxy-5-
cholesten-3.8-ol 
- 11.8,21-dihydroxy-4-pregnene-
3,20-dione 
- 2a-cyano-4,4,17a-trirnethyl-
17S-hydroxy-5-androsten-3-one 
- 21-hydroxy-4-pregnene-3,20-
dione 
- 3S-hydroxy-5-androsten-17-one 
- (2DS)-20-hydroperoxy-5-
cholesten-313-ol 
- NADPH: ferredoxin oxido-
reductase 
E.C. 1.6. 7.1. 
- D-glucose-6-phosphate: NADP+ 
!-oxidoreductase 
E.C. 1.1.1.49. 
- steroid, reduced-adrenal-
ferredoxin: oxygen oxido-
reductase (116-hydroxylating) 
E.C. 1.14.15.4. 
- steroid, hydrogen-donor: 
oxygen oxidoreductase 
(17a-hydroxylating) 
E.C. 1.14.99.9. 
steroid 21-hydroxylase 
cholesterol side-chain 
cleaving enzyme system 
- steroid, hydrogen-donor: oxygen 
oxidoreductase (21-hydroxy-
lating) 
E.C. 1.14.99.10. 
- cytochrome P-450 containing 
enzyme complex catalyzing the 
conversion of cholesterol to 
pregnenolone and isocapro-
aldehyde (NADPH dependent) 
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LIST OF ABBREVIATIONS 
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a.m.u. 
dpm 
E 
EGTA 
EPR 
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HE PES 
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IUPl,C 
Ki 
Km 
NADP!! 
m/e 
mg 
v 
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- aminoglutethimide phosphate (Elipten ®) 
2-ethyl,2-(4-aminophenyl)-glutarimide phosphate 
- atomic mass unit 
- desintegrations per minute 
- extinction 
- ethylene-glycol-bis(2-aminoethyl ether)-N,N,N' ,N'-
tetra-acetic acid 
- electron paramagnetic resonance 
- relative centrifugal force 
- N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
total concentration inhibitor 
- International Union of Pure and Applied Chemistry 
- inhibitor constant 
- Michaelis constant 
- nicotinamide-adenine-dinucleotide phosphate: 
reduced form 
- mass to charge ratio 
- milligram 
- rate of reaction catalysed by an enzyme 
- value of v when the enzyme is saturated with 
substrate, as given by the Michaelis equation 
CHAPTER L 
INTRODUCTION 
1.1 General 
The enzymic conversion of cholesterol into pregnenolone 
involves a cleavage of the cholesterol. side-chain, yielding 
t~vo fragments: pregnenolone and isocaproaldehyde (fig. 1.1). 
This process, the rate limiting step in the biosynthesis of 
the steroid hormones, is generally known as the "cholesterol 
side-chain cleavage" reaction. All the enzymes required for 
this conversion are located in the mitochondria of the adrenal 
cell, >:.;rhile the main regulating factor is the adrenocortico-
tropic hormone (ACTH) . 
HO 
CHOLESTEROL PREGNENOI..ONE ISOCAPROALDBiYDE 
Fig. 1.1 
In the congenital lipoid adrenal hyperplasia, an inborn 
error of metabolism, described by Prader and Siebenmann (1957), 
the adrenal cortex synth2sizes almost no steroids, but large 
quantities of cholesterol and cholesterol-esters are accumu-
lated in the adrenals. Apparently cholesterol is not converted 
into pregnenolone. To understand the exact nature of this 
defect in pregnenolone synthesis, an understanding of the 
mechanisms involved in cholesterol side-chain cleavage is 
indispensable. 
At the start of this investigation (1971), it was generally 
assumed that cholesterol \vas converted into pregnenolone via 
the intermediates 20a-OH cholesterol, 22R-OH cholesterol and 
11 
20a,22R-di-OH cholesterol (fig. 1.2)- The accumulation of 
cholesterol seen in congenital lipoid adrenal hyperplasia 
suggested that one or more of the enzymes involved in the 
conversion of cholesterol into pregnenolone v;as defect. 
HO 
CHOLESTEROL 
~ CHOLESTEROL 
----~ CHOLESTEROL 
OH 
~R-di-:H CHOLESTEROL 
Fig. L 2 
\Vith an adrenal preparation, obtained post mortem from a 
patient with congenital lipoid adrenal hyperplasia, Degenhart 
et al. (1972) showed that 20a-OH cholesterol was converted into 
pregnenolone but cholesterol was not. This experiment supported 
the hypothesis that the inborn error \Vas localized in the 
cholesterol 20a-hydroxylase. In contrast to these conclusions, 
Burstein et al. (1971), van Lier and Smith (1970) and Lieberman 
et al. (1969) have presented evidence that cholesterol may not 
be converted into pregnenolone via 20a-OH cholesterol. 
This conflicting situation prompted us to investigate the 
pathway by which cholesterol is converted into pregnenolone. 
1. 2 Methods 
The cholesterol side-chain cleaving system consists of an 
NADPH-dependent flavoprotein (adrenodoxin reductase) , an iron-
sulphur protein (adrenodoxin) and a hemeprotein (cytochrome 
P~so)- The latter serves as the terminal oxidase in the electron 
transport from NADPH to oxygen. 
Damaged bovine adrenal cortex mitochondria were generally 
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used to study the conversion of cholesterol and other sterols 
into pregnenolone. In the present study the reaction was 
supported by a NADPH-generating system, while substrates, 
intermediates and products were estimated by gas-liquid 
chromatography. 
The objective of this investigation, as mentioned earlier, 
'Has to investigate the pathway (s) by which cholesterol can be 
converted into pregnenolone and isocaproaldehyde. Reaction 
conditions v1ere chosen in such a way that a maximum amount of 
substrate ~.;as converted into pregnenolone in a minimum amount 
of time; hence a maximum amount of intermediates could be 
ex9ected. Possible intermediates which can be measured by gas-
liquid chromatography, could also be indentified by the combi-
nation of gas-liquid chromatography and mass-spectrometry. 
Identification of such intermediates might be of help in the 
elucidation of the com~licated cholesterol side-chain cleavage 
reaction. 
Once the number of 02 and NADPH molecules required for the 
conversion of 1 molecule cholesterol (or 22R-OH cholesterol) 
into 1 molecule pregnenolone is known, the nUMber of theo-
retically possible pathways for the side-chain cleavage 
reaction would be considerably reduced. To calculate the 
stoichiometry of this reaction with respect to oxygen, intact 
bovine adrenal cortex mitochondria were used, supported by 
succinate and malate. 
It has been reported that administration of aminoglutethimide 
phosphate (Elipten) to animals mimics in vivo the congenital 
lipoid adrenal hyperplasia to a certain degree (Goldman, 1970), 
while in vitro Elipten inhibits the cholesterol side-chain 
cleaving system (Kant and Neher, 1969)- Therefore the inter-
action between this drug and the enzyme-system was studied. 
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1.3 Nomenclature 
Several excellent articles and books exist (Trager, 1977) 
explaining "classical" steroid no:r.tenclature. No attempt ·will 
therefore be made to revievl here the matter of axial and 
equatorial bonds, cis and trans joining of rings, etc. There 
is, ho~!Jever, less information available to workers in the 
steroid field concerning the more recent Cahn-Ingold-Prelog 
system. This system, specifying 3-dimensional configurations 
is widely used in organic chemistry, but many biochemists and 
endocrinologists educated at a medical school are not yet 
accustomed to its formalism. 
t'le take as an example the (unstable) corn:r.Jound 
NH2 I 
HO-C-CH I • 1 -hydroxy, 1 - aminoethone 
H 
Fig. 1. 3 
The four substituents -H, -CH 3 , -NH 2 and -OHare given a 
priority, depending upon the atomic numbers of the atoms to 
the central C-atom. 
H 1; C = 6; N = 7 and 0 8. The priority sequence becomes: 
0 I 
N II 
C III 
H IV (lowest priority) 
Now the molecule is positioned in such a \Vay that the substituent 
with the lowest priority, in this case the H-atorn, is the 
farthest away from the observer. 
Fig. 1. 4 
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(I I) 
NH2 
~C-""" CH3 (Ill) 
(IV) w··-" J 
OH 
(I) 
Going from priority I (-OH) to priority II (-NH2) and next 
to priority III(-CH 3 ) corresponds with a clockwise movement. 
This configuration will be called R (rectus= right). If the 
configuration had been as shown in fig. 1.5, 
Fig. 1.5 
(Ill) 
CH, 
~ 
_c....::::::J NH2 (II) 
(IV) H ,/•''(/ 
OH 
(I) 
the movement I + II + III is counter-clockwise; the configu-
ration is called S (sinister = left) . When two or more of the 
atoms attached to the central C are identical, one has to 
consider the atoms attached to the first ones. This process 
can be continued until the priority is settled. 
Some examples: 
(IV) 
CH, 
I 
H CJ!)_(H q- C-CH (ill)CH 
3 2 3 I 2 3 
(CH2)2 
(II) I 
CH, 
A 
Fig. 1. 6 
(I) 
CF, 
I 
(II) F2 HC-C-CH, (IV) I 
CH2 F 
(Ill) 
B 
(Ill) 
CH, 
I (IV) H-C-CH Q.U_CH I ' ' 
CH2 
(I) I 
CH20H 
c 
In order to assign an R or S configuration to the central 
C-atom without constructing 3-dimensional pictures, one has 
to write the common Fischer projection formulae in such a 
way, that the group with the lowest priority is at the bottom, 
for this group points to the rear. 
Remember that interchanging any two groups in a molecule yields 
w 
I 
z-c-x 
I 
y 
Fig. 1.7 
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a mirror image, so that two consequent interchanging pro-
cedures yield the original structure. 
Compound A has the configuration 
Fig. 1. 8 
IV 
1+111 
II 
II 
wh;ch ;, the "'me"' Ill +I 
IV 
r---.n--.rn is counterclockwise: A hos the S configuration 
On manipulating the molecule B, one finds that it has the R 
configuration. The same is true for compound C. 
In the case of 20~-hydroxycholesterol the priority sequence 
for the groups attached to C2o is as follows: 
CH 
(Ill) / ' 
(IV) CH, (CH2) -C-H 
"/ ' " C-OH (I) CH, 
I (II) C···H /"'-c c 
Fig. 1. 9 
or, in short 
Ill 
IV+I 
II 
ond identical 
with 
I 11+111 
IV 
Using the new nomenclature the compound 20a-hydroxycholesterol 
should be called 208-hydroxycholesterol. When, however, c22 
carries an additional hydroxylgroup (orientation not important; 
we'll call it ~) the priority changes. 
CH, 
(II) / 
(IV) CH, CHOH-(CH2~ -C-H 
"/ " C-OH CH3 I (I) 
(Ill) C •· ·H /"'-c c 
r-u-nr is clockwise. 
Fig. 1.10 
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II 
;, •ho,t IV + I 
Ill 
which is the 
same os 
I 
111+11 
IV 
The systematic name of 20a,22S-di-hydroxycholesterol is 
therefore 20R,22S-di-hydroxycholesterol. 
Using the same priority rules it is also possible to 
designate the configuration about double bonds. The expressions 
11 Cis" and "trans" are ambiguous and should no longer be used. 
A plane P, perpendicular to the molecule plane, is thought 
to divide the molecule in two halves. 
Fig. L 11 
I, II, Ill and IV ore groups 
with decreosing priority 
This plane P bisects the angles between groups I and II and 
the angle between groups IV and III. In this example the first 
C-atom has its highest priority group {I) on the left side of 
plane P and the second C-atom has its highest priority group 
{III) at the right side. This configuration is called E 
(from "entgegen"). If group III had been at the left side, 
the groups with highest priority had been at the same side of 
plane P. In this case the configuration would have been Z 
(from "zusammen") . 
Example: 
(IV) 
(Ill) CH, H 
" / C=C CH3 I "-.. / 
(I) C··· H CH:~;-CH2-C-H 
/ "-.. (II) "-.. 
C C CH3 
Fig. 1.12 
(I) and (II) are at the same side of the reference plane; this 
structure has the z-configuration. The reader who wants an 
explanation for more complicated cases, finds a good start in 
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the book by Allinger et al. (1976). 
A major disadvantage of the R-S and E-Z systems is the fact 
that minor changes in a molecule can dictate whether the 
configuration receives another name. 
Example: 
20a-hydroxycholesterol 
20a,22s-di-hydroxycholesterol = 
17a,20a,22~-tri-hydroxycholesterol 
20S-hydroxy-
cholesterol 
20R,22s-di-hydroxy-
cholesterol 
l7S,20S,22s-tri-hydroxy-
cholesterol 
l6s,20a,22s-tri-hydroxycholesterol = l6s,20R,22s-tri-hydroxy-
cholesterol 
etc. 
On the other hand it is possible to construct an exact 3-dirnen-
sional model once the configuration is known to be R or s. 
As many authors {and suppliers of biochemicals) still use a 
mixture of the Fischer (a;S) and Prelog (R,S) conventions, we 
decided to conform ourselves to the most common nomenclature. 
Therefore names like 20a-hydroxycholesterol will be used 
throughout this thesis. In the list of trivial names and 
abbreviations all the IUPAC names can be found. 
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CHAPTER 2. 
REVIEW AND STATEMENT OF THE PROBLEM 
2.1 Introduction 
The presence of an llS-, 17a- and 21-hydroxylase system in 
the adrenal cortex caused several authors to suggest that 
similar hydroxylases are involved in the cholesterol side-
chain cleavage. Much energy has been invested in the isolation 
and identification of possible intermediates of the cholesterol 
side-chain cleaving system, because knowledge of the identity 
of an intermediate may provide information about the enzymic 
activity required for the formation of the intermediates. 
2.2 Review of the literature from 1954 till 1972 concerning 
cholesterol side-chain cleavage 
Over 20 years ago Stone and Hechter (1954) showed that 
adrenocorticotropic hormone stimulated steroidogenesis at a 
site between cholesterol and progesterone. In the same year 
this group found that bovine adrenal gland homogenate, 
supported by NAD+ and ATP, converted labeled cholesterol into 
labeled pregnenolone (Saba et al. 1954). One month later Lynn 
et al. (1954) reported that isocaproic acid was formed from 
cholesterol with enzyme preparations from beef adrenals, 
ovaries, testes and rat liver. They found neither pregnenolone 
nor progesterone. These two short communications in the Journal 
of the American Chemical Society were followed by a full paper 
in the Journal of Biological Chemistry (Staple et al. 1956), 
describing the conversion of cholesterol into pregnenolone and 
isocaproic acid. Addition of 22-keto-cholesterol (fig. 2.1) and 
22-hydroxycholesterol (a mixture of 22R and 22S-hydroxy-
cholesterol) did not interfere with the side-chain cleaving 
system. These substances were not radioactive on isolation 
after incubation with labeled cholesterol and the authors 
concluded {Staple et al. 1956): "These two compounds are there~ 
19 
fore not intermediates. For this reason it does not appear that 
the initial oxidative attack begins at carbon atom 22 in the 
side-chain 11 • 
HO 
Fig. 2.1 
0 
" 
The finding that cholesterol was converted into pregnenolone 
and isocaproic acid led Solomon et al. (1956) to investigate 
the possibility that 20a-hydroxycholesterol is an intermediate 
in the process. These investigators tried to trap the iso-
topically labeled hydroxysterol in an in vitro experiment using 
homogenates of bovine adrenal glands, (4- 14 C) cholesterol as a 
substrate and 20a-hydroxycholesterol as trapping agent. 
Although 20a-hydroxycholesterol isolated from the incubation 
mixture appeared to be associated with 14 C radioactivity, the 
authors were unable to ensure the radiochemical homogeneity 
with certainty since the small quantity of available material 
precluded further manipulation. 
According to Dorfman (1957) the studies of Solomon et al. 
(1956) suggested that 20a-hydroxycholestero1 could be an inter-
mediate. He formulated the following hypothesis: the formation 
of pregnenolone from cholesterol involves two prior 
hydroxylations; one at carbon 22 and the other at the 2Qa 
position. The 20a,22-dihydroxy derivative of cholesterol is 
then degraded by a desmolase to form pregnenolone. Dorfman 
(1957) further speculated that 20a-hydroxycholesterol might be 
a key intermediate in the formation of C19 steroids from 
cholesterol. The 17a-hydroxylation of 20a-hydroxycholesterol 
would lead to 17a,20a-di-OH cholesterol which under influence 
of a proper desmolase might yield dehydro-epiandosterone 
directly (fig. 2.2). The latter suggestion has been 
20 
investigated by Jungman (1968a,b) but was later disproved by 
Hochberg (1971) and Burstein (1971). 
HO 
CHOLESTEROL 
Fig. 2.2 
~ #0 ~ ~«=R~ ~ + }~ 
CHOLESTEROL CHOLESTEROL PREGNENOLONE ISOCAPROALDEHYDE 
~ 17,20-di-OH 
CHOLESTEROL 
w\ 1)---J+Y'L-< 
DEHVDRO-EPI- 6-METHYL-2-
ANOROSTERONE HEPTANONE 
Two groups of workers, Constantopoulos and Tchen (196la) 
and Shimizu and his colleages (1960) reported further attempts 
to clarify the possible intermediacy of 20a-OH cholesterol. 
The latter group incubated labeled 20a-OH cholesterol with a 
preparation made from bovine adrenals and showed that it was 
efficiently converted into pregnenolone and isocaproic acid 
(Shimizu et al. 1960, 1961). The yield of labeled isocaproic 
acid was 15 to 20%. Under identical conditions 0.8% of labeled 
cholesterol was converted to the same acid. The more efficient 
cleavage of the hydroxylated cholesterol by the tissue prepa-
ration was interpreted as strong evidence for the intermediacy 
of 20a-OH cholesterol in the biosynthetic pathway leading from 
cholesterol to the C21 steroid (Shimizu et al. 1960). In the 
presence of relatively large amounts of carrier pregnenolone a 
compound X was seen to accumulate during incubations of 20a-OH 
cholesterol with adrenal cortex preparations. Incubations of 
compound X with an adrenal supernatant, supported by NAD+ and 
ATP, resulted in the formation of pregnenolone and isocaproic 
acid. The yield of isocaproic acid from compound X was signi-
ficantly higher than from 20a-OH cholesterol incubated simul-
taneously (Shimizu et al. 1961). It was speculated that 
compound x was identical with 20a,22-keto-cholesterol. The 
immediate precursor of compound X probably was the 20a,22R-
di-hydroxylated derivative which could arise from the enzymic 
hydroxylation of 20a-OH cholesterol. According to the authors 
(Shimizu et al. 1961) the rate limiting step in the overall 
sequence as observed in the experiments was the C-20-22 des-
molase activity; hence the accumulation of compound X. In 
fig. 2. 3, the biochemical sequence is shown: Cholesterol _,.. 
20a-OH cholesterol + 20a,22R-di-OH cholesterol + 20a,22-keto-
cholesterol _,.. pregnenolone + isocaproic acid. 
~~~ 
20o:-OH 20o:,22R-di-OH 20o:OH,22 KETO 
CHOLESTEROl CHOLESTEROL CHOLESTEl'!OL 
HO 
PREGNENOLONE ISOCAPROALDEHYOE 
Fig. 2.3 
In 1961 Constantopoulos and Tchen (1916a) synthesized 
isocaproic aldehyde and tested this aldehyde as a trapping 
agent. The aldehyde inhibited the formation of isocaproic 
acid from 26- 14 C cholesterol by more than 80% and led to the 
accumulation of labeled isocaproic aldehyde. The experiment 
established the primary product of cholesterol metabolism as 
isocaproic aldehyde and not isocaproic acid. In the same year 
the authors reported that NADH or NADPH was required for the 
conversion of 20a-OH cholesterol into pregnenolone (Constan-
topoulos and Tchen 196lb). The obligatory role of NADPH had 
also been observed by Halkerston (1959) for the formation of 
labeled isocaproic acid from (26 - 14 C) cholesterol. 
22 
Constantopoulos and Tchen (1961b) discussed a number of 
possible pathways for the conversion of cholesterol into 
pregnenolone. One of these pathways implicated the formation 
of a double bond between carbon atoms·2o and 22 and a sub-
sequent cleavage by molecular oxygen. According to the authors 
the cleavage should not require NADPH and the formation of a 
double bond was therefore rejected. For this concept the 
authors referred to a review by Mason (1957). The observed 
requirement of a reduced pyridine nucleotide, which is 
characteristic for hydroxylation reactions, indicated to the 
authors that 20,22-di-hydroxy- and 20-hydroxy-22-keto-
cholesterol were involved in the biogenesis of pregnenolone. 
(fig. 2.3). 
Shimizu et al. (1962) described the identification of the 
earlier mentioned compound X. 20a,22-keto cholesterol, 20a, 
22R-di-OH and 20a,22S-di-OH cholesterol were synthesized. 
These compounds were chromatographed on paper in a toluene-
propyleneglycol system. Com?ound X showed exactly the same 
chromatographic behaviour as 20a,22R-di-OH cholesterol. After 
elution extraction and evaporation to dryness the residue was 
recrystallized twice from aqueous methanol. The specific 
activity remained constant. The formation of pregnenolone 
from 20a,22R-di-OH cholesterol (compound X) by incubation with 
adrenal enzyme preparations had already been demonstrated 
(Shimizu et al. 1961). Incubation of the three synthesized 
compounds showed that 20a,22R-di-OH cholesterol was the most 
efficient precursor of pregnenolone. Reduced pyridine 
nucleotide was necessary for, or at least accelerated, this 
conversion. It was concluded that since 20a,22R-di-OH choles-
terol (compound X) was the most efficient precursor of 
pregnenolone, it was likely that pregnenolone arised directly 
from compound X and not from 20a,22-keto-cholesterol. The 
following scheme for the pathway from cholesterol to preg-
nenolone was suggested: Cholesterol + 20a-hydroxycholesterol + 
20a,22R-di-hydrqXychplesterol + pregnenolone + isocaproic 
aldehyde (fig. l. 2) . 
Constantopoulos et al. (1962) reached a similar conclusion. 
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A polar intermediate was found by incubating (4- 14 C) or 
{26- 14 C) cholesterol in the presence of NADPH, pregnenolone 
and progesterone. Re-incubation of this polar material with 
soluble enzyme and NADPH resulted in the formatiOn of labeled 
pregnenolone or isocaproi--c acid, depending on the original 
position of 14 C in the labeled cholesterol. Whenla mixture 
of (4- 14 C) and {26- 14 C) labeled polar intermediate was treated 
overnight at room temperature with lead tetra-acetate in 
methanol, labeled pregnenolone and isocaproaldehyde were 
formed. According to the authors, these results clearly esta-
blished the nature of the polar intermediate as 20,22-di-
hydroxycholesterol, presumably with the 20-0H group still in 
the ~-configuration. 
Another possibility for the sequence of the hydroxylations 
in cholesterol side-chain cleavage was suggested by Chaudhuri 
et al. (1962). (3- 3 H) 22-keto-cholesterol (fig. 2.1) was 
synthesized, which upon reduction irlith sodium borohydride 
produced an isomeric mixture of 22-hydroxycholesterols. When 
incubated with an adrenal enzyme preparation (3- 3 H) 22-hydroxy-
cholesterol gave rise to (3- 3 H) pregnenolone in a yield 
exceeding the one obtained from cholesterol. 22-Keto-cholesterol 
was not converted into pregnenolone. It was. suggested that in 
addition to the reaction sequence via 20a-OH cholesterol 
another sequence might exist: Cholesterol + 22-hydroxycholes-
terol + 20a,22-hydroxycholesterol +pregnenolone (fig. 1.2). 
According to my opinion this scheme, proposed by Chaudhuri, 
represents the end of a chapter in the history of the studies 
concerned with cholesterol side-chain cleaving system. This 
scheme, also known as the "classical" scheme, is still supported 
by many investigators and it is depicted in most textbooks. 
Let us summarize the e~idence for the classical scheme. The 
first intermediate was isolated by Solomon et al. (1956). The 
proof of its identity was restricted to consideration of 
chromatographic properties, which v1ere similar to those of 20~-
0H cholesterol in two chromato~raphic systems. An analogous 
finding was reported by Halkerston et al. (1961) who referred 
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to unpublished experiments. From this time till 1963 no other 
investigator reported the identification of 20a-OH cholesterol 
as an intermediate. However, 20a-OH cholesterol was accepted 
as an intermediate by almost every author at that time. A 
second intermediate, 20a,22R-di-OH cholesterol, was found as 
a metabolic product of 20a-OH cholesterol. Here paper chromato-
graphy and twice recrystallisation to constant specific activi-
ty had to prove the identity. The polar intermediate of 
Constantopoulos was "identified" via treatment with lead tetra-
acetate, which yielded pregnenolone and isocaproaldehyde. 
Arguments that were used to support the role as an intermediate, 
were: 20a,22R-di-OH cholesterol was more efficiently converted 
into pregnenolone and isocaproic aldehyde than 20a-OH choleste-
rol; 20a-OH derivative was more efficiently converted than 
cholesterol. These latter arguments were in fact based on enzyme 
kinetics. Other pathways were ruled out in view of the fact that 
the conversions were NADPH dependent, which fitted in the ideas 
of mixed function oxygenase held at that time. For the same 
reason ~zo-zz cholesterol was ruled out as an intermediate. 
In conclusion, we want to state that no firm evidence for 
the intermediacy of 20a-OH cholesterol or 20a,22R-di-OH choles-
terol was presented, but it was made less likely that 20a,22-
keto cholesterol was an intermediate. 
After 1963_one can distinguish two main groups of investiga-
tors: Those who isolated labeled 20a-OH cholesterol from incu-
bations with labeled cholesterol as a substrate, and those who 
did not. 
Ichii et al. (1963) reported that 20a-OH cholesterol and 
20a,22R-di-OH cholesterol accumulated when an acetone powder 
of bovine corpus luteum was incubated in the presence of 
added pregnenolone. 
Hall and Koritz (1969) reported that both 20a-OH cholesterol 
and pregnenolone inhibited the conversion of labeled choles-
terol into pregnenolone. 20a-OH cholesterol used as a trapping 
agent yielded the result that no radioactivity was found in 
the 20a-OH fraction. The authors explained their findings with 
the assumption that there might be a specific binding between 
the enzyme and 20a-OH cholesterol, 
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preventing the mixing with added 20a-OH cholesterol. In 
contrast to the above report, Menon et al. (1965) claimed the 
isolation of the intermediate 20a-OH cholesterol from a mito-
chondrial fraction prepared from rat testis. The labeled 
intermediate behaved like authentic 20a-OH cholesterol on 
several paperchromatograms. After repeated paperchromatography 
and dilution with carrier 20a-OH cholesterol, the material was 
crystallized to constant specific activity. 
The purification of a "cholesterol-20a-hydroxylase" from 
hog adrenal mitochondria was reported by Ichii et al. (1967). 
They claimed that addition of adrenodoxin (non-heme iron 
protein) to their acetone powder preparation was obligatory 
for side-chain cleaving activity. The identity of the inter-
mediate (in the presence of labeled carrier 20a-OH cholesterol) 
was established by repeated paper- and thin layer chromatography. 
No significant change in 14C to 3 H ratio was observed as a 
result of these chromatographic treatments. 
Simpson and Boyd (1967) reported that the inhibition of 
cholesterol side-chain cleavage by carbon monoxide was reversed 
by light (450 nm), suggesting the involvement of the heme-
containing protein cytochrome P-450. Working with sonicated 
bovine adrenal cortex mitochondria, they were unable to find 
hydroxylated derivatives of cholesterol. The inhibition of 
cholesterol side-chain cleavage by 20a-OH cholesterol (Hall & 
Koritz,1964) was confirmed and extended to 24-0H, 25-0H and 
26-0H cholesterol. Simpson and Boyd (1967) were the first (at 
least in this field} in critizising the criteria for interme-
diacy of a certain compound. They stated that the strongest 
evidence for the involvement of 20a-OH cholesterol and 20a,22R-
di-OH cholesterol as intermediates in the reaction was the fact 
that they are more efficient precursors of pregnenolone than 
cholesterol. However, the same had been shown to be true for 
22-hydroxycholesterol (Chaudhuri, 1962), while 20a-OH,22-keto-
cholesterol (Shimizu et al. 1962} and 25-0H cholesterol 
(Burstein and Gut, 1971} a~e also converted into pregnenolone 
but had been ruled out as obligatory intermediates (Burstein 
and Gut, 1971; Constantopoulos et al. 1962, 1966). Simpson and 
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Boyd (1967) stated: "Thus if ability to be metabolized to 
pregnenolone is accepted as evidence for involvement as an 
intermediate, it is necessary to assume several possible 
pathways, which seems somewhat unlikely". A possible role of 
20a-OH cholesterol and 20a,22R-di-OH cholesterol as inter-
mediates was not ruled out by Simpson and Boyd. They assumed 
that the cleavage of the cholesterol side-chain was a 
concerted reaction in which the sterol molecule is bound to 
the enzyme along with molecular oxygen in a transition-state 
complex until the side-chain is liberated. 
With double-isotope dilution techniques Roberts et al. 
(1969) showed that bovine adrenal glands contained 100 ~g/kg 
unesterified and esterified 20a-OH cholesterol. t-Jith similar 
techniques Dixon et al. (1970) showed that bovine adrenal 
glands contained 1500 ~g/kg 22R-OH cholesterol and 2150 ~g/kg 
20a,22R-di-OH cholesterol. 
A breakthrough was reported by Burstein et al. {1970a,b; 
1971). At relatively low substrate concentrations the conver-
sion of cholesterol to 22R-OH cholesterol and 20a,22R-di-OH 
cholesterol (without the use of trapping agents in the 
incubation media) was established using reverse-isotope 
dilution techniques involving chromatographic separation, 
derivative formation, specific reactions and crystallisation. 
The amount of radioactivity found in 20a-OH cholesterol was 
exceedingly small, precluding a significant formation rate 
of this sterol from cholesterol. According to Burstein et al. 
(1970b; 1971), their studies using acetone powder preparations 
from bovine adrenal cortex, established the existence of the 
following pathways: 20a-hydroxycholesterol + 20a,22R-di-
hydroxycholesterol + pregnenolone and cholesterol + 22R-OH 
cholesterol + 20a,22R-di-OH cholesterol + pregnenolone 
(fig. 1.2). The rate of disappearance was measured for 
cholesterol and its hydroxylated derivatives. Using first 
order Michaelis-Menten kinetics the first order rate constants 
were calculated, assuming overall irreversibility. Co~parin~ 
the experimental results with their theoretical models it was 
suggested that the major fraction of pregnenolone arose by an 
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one-step (or,direct) enzymatic reaction: Cholesterol+ 20et., 
22R-di-OH cholesterol. The second most important sequence 
was the one involving the conversion of cholesterol into 
22R-OH cholesterol followed by an one-step transformation of 
22R-OH cholesterol into pregnenolone. From their calculations 
it was concluded that the sequences, cholesterol + 20et.-OH 
cholesterol + 20et.,22R-di-OH cholesterol + pregnenolone and 
cholesterol + 22R-OH cholesterol + 20et.,22R-di-OH cholesterol 
+ pregnenolone accounted for a relatively small fraction of 
the experimentally found pregnenolone. The pathways involving 
20et.-OH cholesterol were quite insignificant. 
Another pathway for the conversion of cholesterol into 
pregnenolone has been suggested by van Lier {1970) who showed 
that 20et.-hydroperoxycholesterol (fig. 2.4) was converted into 
20et.,22R-di-OH cholesterol. This reaction was catalysed by an 
acetone powder of bovine adrenal cortex and proceeded in the 
absence of NADPH and oxygen. The enzymatic conversion of 
cholesterol into the 20et.-hydroperoxy derivative has however 1 
not been reported. According to the proposal only a single 
molecule of oxygen was involved in the formation of 20et.,22R-
di-OH cholesterol from cholesterol. 
HO 
20 <X- HYOROPEROXY CHOLESTEROL 
Fig. 2.4 
A synthetic analog of 20et.-OH cholesterol 1 completely 
substituted with CH 3 -groups at C-22 has been synthesized by 
Luttrell et al. (1972). According to these authors oxygenation 
at c-221 if necessary for cleavage, could only occur simul-
taneously with fission of the C20-22 bond. Hence the involve-
ment of stable 1 di-oxygenated intermediates analogous to 20et., 
22R-di-OH cholesterol was not possible in these transformations. 
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Also the hydroxylated compounds 20a-OH cholesterol and 22R-
OH cholesterol were not obligatory intermediates. The hydroxy 
sterols were considered to be by-products from as yet undefined 
reversible transformations of the true intermediates. The 
mechanism of the cleavage reaction involved reactive, transient, 
ill-defined intermediate complexes, which could be represented 
either as radical or ionic species. 
In summary, it is concluded that in 1972 the possible path-
ways for the conve~sion of cholesterol into pregnenolone 
included: 
a) The classical scheme involving hydroxylations at C-20 and 
C-22 with formation of 20a,22R-di-OH cholesterol. The 
intermediates were isolated from the incubation medium. 
(Burstein et al. 1970b; 1971). 
b) A cleavage mechanism involVing ionic or radical interme-
diates. These intermediates could not be isolated from 
the medium. Compounds that were isolated were merely by-
products from the true intermediates. (Lieberman et al. 
1969; Luttrell et al. 1972). 
c) A cleavage mechanism involving the formation of 20a-
hydroperoxycholesterol. This compound was further converted 
into 20a,22R-di-OH cholesterol. (van Lier and Smith 1968, 
1970' 1972). 
2.3 Statement of the problem 
In this literature survey up to 1972, when we started our 
investigation, several mechanisms for the conversion of 
cholesterol into pregnenolone had been suggested. Firm 
evidence had not been presented for any of these hypotheses. 
A satisfactory model for cholesterol side-chain cleavage could 
not be constructed at that time. Such a model was considered 
essential for any study concerning inborn errors in steroid 
biosynthesis of the congenital lipoid adrenal hyperplasia type. 
Therefore it was attempted to construct a model, fitting all 
well established observations. 
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CHAPTER 3. 
METHODS 
3.1 Introduction 
For a quantitative evaluation of the cholesterol side-chain 
cleaving activity radioactive {exogenous) substrate is often 
used. However, incubation studies with tracer amounts of radio-
active cholesterol are complicated by the possibility that the 
radioactive precursor is not taken up or does not completely 
mix with the endogenous cholesterol pool and therefore the 
results obtained may not reflect true production rates. To 
circumvent this problem the mitochondria are often treated with 
acetone which removes most of the cholesterol, but by this 
treatment the activity of the enzyme(s) is considerably 
diminished, while ah•rays some cholesterol remains in the 
residue. 
An additional problem arises when the formation of inter-
mediates of the side-chain cleavage reaction is studied, using 
an acetone powder of bovine adrenal cortex mitochondria. The 
isolation of the very low amounts of radioactive intermediates 
requires laborious techniques. 
Using an acetone powder, prepared from bovine adrenal cortex 
mitochondria, Burstein et al. {1971) reported the isolation of 
radioactive labeled 22R-OH cholesterol and labeled 20a,22R-di-
OH cholesterol upon the incubation of labeled cholesterol with 
an adrenal preparation. Their technique depended on the 
isolation of small quantities of steroids by column chromato-
graphy. Identification of the labeled compounds was performed 
via crystallisation to constant specific activity. If the 
radioactive labeled compound and the added unlabeled compound 
are identical, the specific activity (dpm/mg) must remain 
constant during the recrystallisation steps. Unfortunately this 
method is not fully reliable (Hochberg et al. 1976b). Moreover, 
the assumed intermediate must be commercially available or has 
to be synthesized in a purity exceeding 99%. In addition, the 
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isolation method via column chromatography is very laborious. 
For the present studies gas-liquid chromatography was used for 
isolation and characterisation of reaction products. The major 
advantages of this technique are: 
A) a high resolution, which enables one to detect several 
sterols and steroids in one gaschromatographic run. 
B) the possibility to couple the gaschromatograph to a mass-
spectrometer. 
In this way a'compound can be identified by its retention time 
on the gaschromatographic column as well as by its mass-
spectrum. From the information contained in the mass-spectrum 
it is often possible to locate the site of incorporation of a 
label. In the present study (non-radioactive) H2 18 0 was used. 
The labeled oxygen atom is two mass units heavier than the 16 0 
present in air and in water. With the combination of GC-MS the 
site of 18 0 incorporation in pregnenolone and in 20a,22R-di-OH 
cholesterol upon incubation of mitochondria in the presence of 
H2 18 0 was determined. 
Compounds that are not volatile or compounds that decompose 
on heating at 200 - 300°C elude gaschromatographic detection, 
but these disadvantages can sometimes be useful as will be 
shown in chapter 5. 
3.2 Stoichiometry 
The stoichiometry of the side-chain cleavage reaction with 
respect to oxygen was used in the present investigation as a 
useful tool to construct a model for the conversion of 
cholesterol into pregnenolone. Once the stoichiometry of the 
reactions with respect to oxygen is known, the theoretical 
number of possible pathways (and intermediates) is considerably 
reduced. If an experimentally obtained stoichiometric relation-
ship is not compatible with that of the hypothetical scheme, 
the scheme should be rejected. 
Introduction of a hydroxyl group at C-11 of deoxycorti-
costerone converts this compound into corticosterone. The mono-
oxygenase reaction is catalyzed by cytochrome P-450 1 lS and is 
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located in the inner membrane of the bovine adrenal cortex 
mitochondria. The reaction requires NADPH and oxygen: 
l steroid-H + 1 NADPH + 1 H+ + 1 02 ~ 
l steroid-OH + l NADP+ + l H2 0. 
According to the classical scheme, which involves two 
consecutive mono-oxygenase reactions and a cleavage between 
C20 and C22 , side-chain cleavage of cholesterol would require 
3 mol oxygen. Also according to the epoxide-diol hypothesis 
(see chapter 6) 3 mol oxygen are required for the conversion 
of cholesterol into pregnenolone. 
During our investigations the oxygen requirement for side-
chain cleavage of cholesterol, 200'.-0H cholesterol and 20a, 22R-
di-OH cholesterol was reported (Shikita and Hall, 1974). There-
fore we investigated the same relationship for 22R-OH 
cholesterol, which in our opinion is a more likely intermediate 
than 20a-OH cholesterol. 
3.3 1 ao incorporation 
The incorporation of lao can be studied with a mass spectro-
meter. If the reaction equation, shown in 3.2, is valid, 
addition of H2 18 0 will not result in incorporation of 18 0 in 
the hydroxylated product, for this reaction requires molecular 
oxygen. If, however, lao incorporation does occur with Hz 18 0 as 
oxygen donor, the reaction equation, shown in 3.2, is not valid. 
Hence the incorporation experiment is of importance in studying 
the enzymes involved in the reaction. 
The use of 18 0 has some drawbacks that have not generally 
been recognized up till now. According to the reaction equation 
NADPH and H+ produce in the presence of 18 0 2 and adrenal mito-
chondria, NADP+ and H2 18 0. As a result of this oxidation 
reaction both H2 18 0 and 18 0 2 are at the same time present in 
the rea.ction medium and evidently such a situation should be 
avoided. Therefore in our experiments H2 18 0 was used as 18 0-
donor. 
If necessary, 18 02 can be prepared from H2 1 ao via Hg { 1 aOH)2. 
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I. Introduction 
Several models of cholesterol side-ch:.~in cleavage 
have been proposed. but none of them has found 
general accept:mce [1-3]. The schemes favoured by 
most authors presently working in this field are (a) 
t\\"Q consecutive hydroxylations of cholesterol ut 
carbon atoms 20 and 22 (the classical scheme) and 
(b) a Concerted att.::J.ck of o>..ygen with the form:.~tion 
of 20a:, 22R-di-OH l:holcstcrol. The vicinal glycol is 
cleaved to yield pregnenolone and isoc.::J.proaldchyde. 
It has been found th.::J.t .20Q·OH cholcskrol. 20a:, 
22R-di-OH chvlcsterol and 22R-OH cholesterol arc all 
effective precursors of p1cgncnolone in adn.:n;:d tissue 
[I ,2]. Burstein and Gut )2.4.5] wen: able to isolate 
labelled 20a:, 2::!R-di-OH ..:Pvlcsterol and 22R-OH 
cholesterol when bbellcti chvlcsterul was :tddt:d tt> 
Nnmcnclatun: and u.bbrcJ'io.~tions: 
HF PES: N-2-hrdrcx;. cthylpipcrJzin~·.'\: -~ c>~l!an~> .. l fuui~ :1~kL 
EGT A: i:tnylcnc ~~lycnl-bb-1!.1·~ mi:'J,,-~,hyktl\,•rl:\',;\'' -t••t,;.~;,cctic· 
~cid. 
Cyanu~:cton~: 2(>·cyano4,..J-, I 7c,·trimc•thyl·l 71,."·11;-·droxpndrost-
5-cn-3-on~. 
Cholc.>tewt· 5 ·~lh>kstcn·J)J·oL 
2(Je:-OH chnk,t~rol: 5-dl.:>l~:~lcn-3;3,20.:..-UJ<>l. 
22R-OH ~h·Jkstn,,l: (22 RJ-5·dh,lc~t..:n-3 1J,2:>.-ilnl. 
20<>,22 R-di-011 cilnk~tcrol: t22R}-5-d11'lk~t..:n·3)J,20u,22-trioJ. 
..:l.' 0 -': chulcstcrul: 5.201 221-cholcst:~.dicn-3)3-ol. 
..:l.17 -•o dwlc~:tcrol: S.l7(20J-<.:holcstadien-3i)-ul. 
6.: 0 -' 1 c'ilolcstcrvl; S.20t 21 h:holcstadicn-3J,l-ol. 
20,2 2....: poxych ok~ l•'H• \ : 20. 22 ....:poxy-5 -~hoksh: n· 3;3·• 11. 
L!homtory !'or Toxtcolof!y. StJt~ UniwP.>ity Utrecht. 
The Nctlwrlands. 
an acetone powder of bovine adrenal cortex mito-
chondria. Their calculations suggest that 20a:. 22R-
di-OH cholesterol is an intermediate of the cholesterol 
side-chain cleav::t.gc reaction. They also presented 
evidence that pregnenolone formation via the 
'classici:] pathway' is insignificant and their results 
strongly indicate the existence of other (as yet un-
idcntiticd) pathways. 
From the experim(:nts of Wilson [6] and Burstein 
[2] it is evident that a correlation exists between the 
rate of oxygen uptake and the rate of pregnenolone 
formation when 2:2R-OH cholesteroL 200', 22R-di-
OH t:holesterol and 20a:-OH cholesterol are added to 
.::J.dri.!nal cortex mitochondria. This correlation was 
used as a screening method fur potential intermediates 
of the cholesterol side--::hain de::~vagc reaction. 
The results of vur studies cannot be explained by 
tile models proposed until now. Therefore a new 
model will be suggesteJ in this paper. Preliminary 
results vf this work haw been presented elsewhere 
[7 -9]. 
2. Materials and mdhods 
Bovine adrenal corkx mitochondria were prepared 
Jccurding to standard pmccdures, Only mitochondria 
with a respiratory control ratio (succinate)~ 3 were 
used . 
Oxygen uptake: was measured in a thermostated 
(37°C) V(:SSe! (voll.3 ml) equiped with a Clark elec-
trode. The medium used contained: 200 mM sucrose, 
20 mlvl KCJ. 10 mM potassiumphosphate, 20 mM 
Nurth-f-lul/1..1nd Pubilshit(~ Company- Arm:terdam 
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HEPES (pH 7.3), 1 niM: EGTA, 1% bovine serum 
albumin (w/v). Further additions are mentioned in 
the legend to fig. 1. 
H2 18 0 incorporation experiments were perfonned 
in a medium (H2 18 0/H2 16 0 = 1 :2) containing 154 
mM KCI, 11.5 niM: NaO, 50 niM: nicotinamide, 20 
mM HEPES (pH 7 .3), 5 mM CaCI,, 4 mM Na,azide, 
1% bovine serum albumin (w/v) with a fmal vol of 
5 ml. Bovine adrenal cortex mitochondria (stored 
under liquid nitrogen) were added to the H2 18 0 con-
taining medium immediately after freeze-drying and 
kept for 30 min at 0° C (procedure a). Procedure b 
consisted of storing freeze-dried mitochondria in con-
tact with the air during 30 min at 0°C, followed by 
addition to the H2 18 0 containing medium. These 
media containing mitochondria (15 mg protein) were 
preincubated at 37°C for 20 min. Additions were 
HEPES PHOSPHATE 
BUFFER pH 7.3, 3~C 
I MITO j S\JCC 
-----l•cN-jAA 
1LATE 
made to achieve a fmal concentration of 30 JJ.M 
cyanoketone. 5 JJ.M antimycin A, 200 JJ.M 200!-0H 
cholesterol or 22R-OH cholesterol. The reactions 
were started by adding NADPH, glucose-6-phos-
phate and glucose-6-phosphate-dehydrogenase to give 
a final concentration ofO.l mM, 3 niM: and 0.6 U/ml 
respectively. Samples taken at 0, 10 and 20 min were 
extracted with ethylacetate, evaporated under nitrogen, 
persilylated with N-trimethylsilylimidazole by heating 
for 1 hr at 95°C in the presence of pyridine hydro-
chloride. 
Gaschromatography: Analytical separations were 
carried out with a Hewlett-Packard 5700A instrument 
equiped with dual flame ionization detectors. The 
glass colunms (2 m X 1.8 mm I.D.) were packed with 
3% SP-2250 (Supelco) on 100-120 mesh Chromosorb 
WAW-DMCS H.P. The conditions were: injector. 
KINETICS OF 0 2 CONSUMPTION 
rDITION OF STEROL 
.6 20- 22 CHOLESTEROL-
MIN. 
0 2 4 6 
F"lg. 1. Effect of the addition of sterols on the :mte of oxygen uptake by bovine adrenal cortex mitochondria. Mitochondria 
(0.9 mg protein) were added to 1.25 ml medium (methods). Additions were made as indicated. Final cor: :entrations were: 10 mM 
succinate, 1 mM potassium cyanide. 5 ~M antimycin A, 10 mM malate, 20 ~M 20a-OH cholesterol, 20 ~M 22R-QH cholesterol. 
20 ~M 1::..~ 0 ~~~ cholesterol. Sterols were added as their ethanolic solutions. 
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250°C. detector 300°C, nitrogen flow rate 30 ml/min. 
The oven was programmed from 236°C to 280°C at 
2°C/min. Peak areas and retention times were meas-
ured with an electronic integrator (Infotronics CRS-
IOOA). 
Mass-spectrometry: The mass-spectra were record-
ed on a Finnigan 10150-6000 GC-MS-computer 
system. The GLC-conditions were equivalent to those 
described above. Helium was used as a carrier-gas. 
The MS-conditions were: jetseparator :lt 250°C, 
source temperature l70°C. ionizing voltage 70 eVand 
ionizing current 500 J.LA. 
A20 - 22 cholesterol was synthesized according to 
Sheikh and Djerassi [ 10]. Protein was estimated using 
the biuret method. 
3. Results and discussion 
The rate of oxygen uptake of intact bovine adrenal 
cortex mitochondria was dramatically increased by 
adding .c::..:l.O-:l.'l cholesterol in comparison to the addi· 
tion of 22R-OH cholesterol and 20o:-OH cholesterol 
(fig. 1). All three substrates were converted into 
pregnenolone. 
Dehydration of 20o:-OH cholesterol produces a mix-
ture oL6. 1 7 -:o. L1.20 -'l~ and L1.20 -~ 1 cholesterol [10]. 
L1.17 - 20 cholesterol proved to be a very efficient inhi-
bitor of the cholesterol side-chain cleavage system. 
Contamination by this inhibitor might be the reason 
why .C::..20 - 22 cholesterol was reported earlier as a very 
poor substrate [2]. 
Combination of our results with the evidence 
available in the literature, allowed us to propose a 
new scheme (fig. 2). whereby cholesterol is converted 
into pregnenolone ::tnd isocaproaldehydc via A20 - 22 
cholesterol. 20,22-epoxycholesterol. 20o:. 22R-di-OH 
cholesterol. 20o:-OH cholesterol and 22R-OH cholester-
ol will lose water to form .C::..20 " 22 cholesterol. 
According to this proposal H2 18 0 should be 
incorporated in 20o:.22R-di-OH cholesterol and the 
18 0-label must be found in pregnenolone or isocapro-
aldehyde. To check this hypothesis 1000 nmol20o:-
OH cholesterol and an equal amount 22R-OH 
cholesterol were incubated in parallel in a H2 u>o con-
taining medium (H2 18 0/H;: 16 0 = 1 :2) in the 
presence of freeze-dried bovine adrenal cortex mito-
chondria. supported by a NADPH generating system 
~ 
~1 ,o, 
~ H~ ~ ~ 
~l '"' 
tr< 
r""' 
0" ~ 
l '"' 
t 0 + l~ 
(methods). After 20 min of incubation at 37°C (pro-
cedure a) 20o:-OH cholesterol was partially convert-
ed; 330 nmol pregnenolone were formed. 22R-OH 
cholesterol was totally converted; 890 nmol pregneno-
lone were produced. Samples from these H2 18 0 incubJ-
tions were extracted, trimethylsilylated and analyzed 
by GC-MS. Their mass-spectra were compared with 
that of synthetic pregnenolone and with those ob-
tained in identical experiments in presence of unlabel-
led water (fig.3). The relative abundance of the M+2 
peak of the 18 0 incorporated pregnenolone shows an 
increase of 170% over the pregnenolone-standard 
(inaccuracy of the measurement: less than 1 0%). It 
could be concluded that water from the medium was 
incorporated in 20% of the product originating from 
20o:-OH cholesterol. No 18 0 could be detected in the 
synthesized pregnenolone (standard). pregnenolone 
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+ H2 180 
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1
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Fig. 3. TI1c measured relative abundances of M-90+2 and M;.2 or the pregnenolone-standard arc in accord to the calculated natural 
abundanc~;s. The mass-spectrum of pregnenolone originating from 2001-0H cholesterol shows an incorporation of '" 0 that can be 
seen from the marked increase in the relative abund:mccs of M-90+2 and M+2. No incorporation was demonstrated in pregneno-
lone formed from 22R-OH cholesterol. 
originating from 22R-OH cholesterol (H2 1 IS 0) and 
pregnenolone from the control experiments. We could 
not demonstrate exchange of 11\0 between the sub-
strates 20o:-OH cholesterol. 22R-OH cholesterol and 
1-h 18 0. The low percentage of incorporation may be 
explained by the amount of water still present in the 
freeze-dried mitochondria and the water produced 
during the reaction (fig. 2). Pregnenolone originating 
from endogenous substrates contributes.::;;; 5% of the 
total pregnenolone production. causing only insignifi-
cant isotope dilution. 
In measuring 18 0 incorporation in 20o:.22R-di-0Ii 
cholesterol, reaction conditions had to be changed 
(procedure b: methods) in order to isolate sufficient 
material for mass spectrometric identification. We 
found that 22R-OH cholesterol was partially convert-
ed and that 180 nmol pregnenolone ::md 157 nmol 
20o:.22R-di-OH cholesterol were formed. No detect-
able incorporation of 18 0 could be found in 
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pregnenolone: however 18 0 was incorporated in 20o:, 
22R-di-OH cholesterol. Analysis of the mass-spectrum 
showed that 18 0 was attached to the carbon·22 atom 
of 20o:.22R-di-OH cholesterol. 20o:-OH cholesterol 
incubated according to procedure b was partially 
converted~ 70 nmol u> 0-incorporatcd pregnenolone 
were formed. The results are summarized in fig. 4. 
Our results complement those of Takemoto et al. 
[11] and Nakano et al. [12] who performed incorpora· 
tion studies with molecular oxygen ct 8 0::)- Incorporat-
ed 18 0 in pregnenolone originating from cholesterol 
and 22R-OH cholesterol was found to be attached to 
the C-20 atom. In the presence of u02 neither 20o:-
OH chOlesterol nor 20o:,22R-di-OH cholesterol was 
converted into pregnenolone containing labelled 
oxygen. 
An explanation for the two different ways of the 
reaction of20.22-epoxycholesterol with water (fig. 4) 
might be found by considering the aconitase reaction. 
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We postulate that 2.20 - 21 cholesterol origin::J.ting 
from 20a:-OH cholesterol is attached to the enzyme 
surface in a stereochemically different way than 
~z 0 - 21 cholcsterol originating from 22R-OH 
cholesteroL This situation would be analogous to the 
aconitase reaction, where cis-aconitate formed by 
dehydr:J.tion of citrate and cis-aconitate formed by 
dehydration of threo-Ds·isocitratc arc bound in a 
stercochcmic::tlly different way [ 13]. 
The proposed scheme (fig. :2) is also in accord with 
the stoichiometry of the reactions with respect to 0 2 
and NADPH. as reported by Shikit:.~ :.~nd Hall [ 14], 
and Kraaipocl et al. [7 ,8 J, The conversion of 1 mol 
of cholesterol into ~20 - 22 cl10lesterol would usc at 
least~ mol of 0 2 to form H2 0 with the removed 
hydrogen. ActiVJtion of cytochrome P-450 [1 S .16] 
with 1 mol NADPII + H+ probably needs another 1 
mol 0 2 . Since the conversion of both 20a:-OH and 
22R-Oli cholesterol to pregnenolone and isocapro-
aldehyde requires 2 mol 0 2 and 2 mol NADPH + H+ 
per mol substr:.tte, :1nd the conversion of ::;Oa:.22R-di-
OH cholesterol needs l mol 0 2 plus 1 mol NADPH 
+ H~. it can be concluded that 1 mol Oz plus 1 mol 
NADPH + H+ are necessary for the conversion of 
.2;20 - 22 cholesterol into 20,22-epoxycholesterol. 
20a.22R-di-OH cholesterol :J.nd 20.2:2-cpoxychol-
csterol could be isolated from reaction media [20]. 
The high conversion rate of~ 20 - 2 :: cholesterol as an 
intermediate has hitherto prevented its isolation. 
Virtually o.ll the d:lta found in the literature con-
cerning cholesterol side-chain cleavage flt nicely into 
this new scheme [2.I7.JS].lts consequences for the 
study of inborn errors in pregnenolone biosynthesis 
[19] will be discussed elsewhere [20]. 
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CHAPTER 5. 
SIDE-CHAIN CLEAVAGE OF 22R-OH CHOLESTEROL BY BOVINE ADRENAL 
CORTEX MITOCHONDRIA * 
5.1 Introduction 
Bovine adrenal cortex mitochondria contain an enzyme complex 
which catalyzes the cleavage of the Cz 0 -Czz bond of cholesterol, 
20a-OH cholesterol, 22R-OH cholesterol and 20~,22R-di-OH cho-
lesterol to form pregnenolone. This complex is usually called 
cytochrome P-450scc· According to the "classical scheme" the 
mechanism of this side-chain cleavage involves hydroxylation 
of Czo and C22 followed by cleavage of the vicinal glycol to 
yield pregnenolone and isocaproaldehyde: 
20e<-OH 
?' "" cholesterol 20~,22R-di-OH 
"" ?' 22R-OH 
pregnenolone + isocapro-
aldehyde. 
A direct conversion of cholesterol into 20~,22R-di-OH 
cholesterol has also been proposed (Burstein et al. 1970b; 
Burstein and Gut, 1971). However, evidence for two sequential 
mono-oxygenases or for a concerted attack of oxygen producing 
the dihydroxycholesterol is still lacking. There are several 
other models of cholesterol side-chain cleavage which also 
lack good experimental evidence (van Lier and Smith, 1970; 
Luttrell et al. 1972). 
we have studied the conversion of 22R-OH cholesterol into 
pregnenolone and isocaproaldehyde. In this chapter we will 
present results on the identity of the intermediate 20a-22R-di-
OH cholesterol which was established by a combination of gas-
chromatography and mass-spectrometry. In addition we found 
that 20a,22R-di-OH cholesterol is not the only intermediate. 
The results suggest 20,22-epoxycholesterol to be an intermediate 
in the same reaction. The experiments support our previously 
presented hypothesis, according to which 22R-OH cholesterol is 
*The results of this chapter have been published in part, 
Kraaipoel et al. (1975b). 
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converted into pregnenolone and isocaproaldehyde via ~ 20 - 22 
cholesterol, 20,22-epoxycholesterol and 20a,22R-di-OH 
cholesterol (chapter 4). 
5.2 Methods and materials 
Bovine adrenals were obtained from a local slaugtherhouse 
and transported on ice to the laboratory within 30-45 min. 
The glands were trimmed to remove fat and cut in half 
longitudinally. The central medulla and a minor portion of 
the adjacent zone reticularis were scraped away and discarded. 
The remainder of the cortex, mainly zona fasciculata, was 
scraped off and collected. A 10% (w/v) homogenate in 250 mM 
sucrose, 0.5 rnM EGTA and 10 rnM HEPES at pH 7.35 was prepared 
using a Potter-Elvehjem homogeniser with a power-driven 
Teflon pestle. The homogenate was centrifuged at 900xg for 
10 minutes at 4°C to remove nuclei, erythrocytes and unbroken 
cells. The supernatant was centrifuged at 9000 g for 10 minutes 
to give the mitochondrial pellet. This pellet was resuspended 
in 250 mM sucrose (one half of the original homogenate volume) 
and centrifuged again at 10.000 g for 10 minutes. This washing 
procedure was repeated once. The final pellet was resuspended 
to obtain a protein concentration of 30-50 mg/ml. Throughout 
the procedure any visible sedimented hemoglobin was carefully 
removed. The mitochondria were stored in liquid nitrogen. 
Conversion of 22R-OH cholesterol (Ikapharm, Israel) into 
pregnenolone was estimated in a medium containing 154 mM KCl, 
11.5 mM NaCl, 50 mM nicotinamide, 20 mM HEPES (pH 7.3) 5 mM 
CaCl2, 4 mM sodium azide, 1% bovine serum albumin (w/v) with 
a final volume of 25 ml. Incubations were carried out at 37°C 
in a thermostatically controlled vessel, the contents of which 
were magnetically stirred. The above 11 freeze-damaged 11 mito-
chondria (23 mg protein) were used. Additions were made to 
achieve a final concentration of 30 ~M cyanoketone (Goldman, 
1967), 5 ~M antimycin A, 0.1 mM NADP, 3 mM glucose-6-phosphate 
and 0.6 U/ml glucose-6-phosphate dehydrogenase. After a 5 min. 
preincubation at 37°C, a sample was taken to correct for the 
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pregnenolone formation from endogenous cholesterol and 1300 
nmol 22R-OH cholesterol were added to the medium. The reaction 
was started by addition of the substrate 22R-OH cholesterol 
and stopped by addition of 6 ml cold ethyl acetate to a 
sample drawn from the incubation, and shaking vigorously. To 
all samples 20 ~g/ml (50 ~M) epi-cholesterol (Steraloids) was 
added as an internal standard. The solvent was evaporated at 
room temperature with nitrogen. The extract was silylated and 
the steroids were quantified by gas-chromatography as des-
cribed in chapter 4. The experiments A and B were conducted 
as shown in fig. 5.1. All glassware had been cleaned with a 
potassium bichromate-sulphuric acid mixture and siliconized 
with Siliclad (Clay Adams). 
Gaschromatographic analysis (fig. 5.7) was performed at 
250°C on a capillary column coated with SE-30, lenght 60 m 
(Rutten, 1972), with a solid state injector (van den Berg, 
1972), equipped with a flame ionisation detector" (full scale 
in fig. 5.2, 1 x 10- 11 A) and with nitrogen as a carrier gas. 
Gaschromatograms obtained with a packed column (3% SP-2250 
on chromosorb WHP, 100-120 mesh) are shown in fig. 5.3, 5.4, 
5.5 and 5.6. 
The mass spectra were obtained by a GC-MS combination as 
described by Leferink et al. (1974). The conditions were as 
follows: temperature of the column 230°C, GC-MS interface 
260°C, source 230°C, accelerating voltage 4 KeV, ionizing 
voltage 70 eV and ionizing current 500 ~A. 
20a,22S-di-OH cholesterol was synthesized according to 
Chaudhuri et al. (1970) using sodium borohydride reduction. 
Protein was estimated by the biuret method. 
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Experiment A: Every minute a 0.5 ml sample was taken and 
extracted with ice-cold ethylacetate. The first sample was 
taken 10 sec. after addition of 22R-OH cholesterol. 
Experiment B: Samples of 2 ml were taken from the same 
incubation at intervals as indicated in fig. 2-B, added to 
25 ml erlenmeyers and immediately flushed with 100% 
carbonmonoxide (Soo ml/min) for 120 sec. The contents were 
sealed off from air and incubated in a shaking incubator 
at 37°C for 20 min. Reactions were also stopped by cold 
ethylacetate. 
5.3 Results 
In fig. 5.2 it can be seen that 22R-OH cholesterol (1300 
nrnol) disappears in 10 min and 1300 nrnol pregnenolone are 
formed. Assuming 20cr,22R-di-OH cholesterol to be the only 
intermediate in the conversion from 22R-OH cholesterol into 
the products, pregnenolone and isocaproaldehyde, the sum 
(nmol) 22R + 20a,22R + pregnenolone must be constant during 
the reaction. However, the sum of the nmol substrate; inter-
mediate and product is not constant. At t=4 min. it is only 
70% of the initial amount of substrate. Therefore 30% must 
be present in a form not detected by our method. The time 
course of formation and disappearance of this or these com-
pound(s) is represented by the shaded area of fig. 5.2. Ana-
lysis of the samples taken from the experiment shown in 
fig. 5.2a, incubated for 20 min. under carbon monoxide,(see 
fig. 5.1) and thus with complete inhibition of cytochrome 
P-450, shows a marked increase in 20a,22R-di-OH cholesterol 
and a proportional decrease in the shaded area (fig. 5.2b). 
Apparently the compounds not measured by our method are 
converted into 20a,22R-di-OH cholesterol in the presence of 
>99% co. 
In fig. 5.4, 5.5 and 5.6 the gaschromatographic analysis 
of samples taken from an incubation similar as described in 
fig. 5.2 is shown. A standard mixture, containing equivalent 
amounts of steroids, is shown in fig. 5.3. 
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~------{ l 22R-OH-CHOLESTEROL 
::r--- -- --~ 22R-OH·CHOLESTEROL+PREGNENOLONE+ 
20oc., 22R·di· OH-CHOLESTEROL 
Conversion of 22R-OH cholesterol into pregnenolone by damaged 
bovine adrenal cortex mitochondria supported by a NADPH-
generating system. 20a,22R-di-OH cholesterol is formed as an 
intermediate. The shaded area represents the apparent "mass-
defect". After trimethylsilylation the steroids were 
quantified by GLC. Samples taken during the experiment, shown 
in fig. 5.2a, were immediately flushed with 100% carbon-
monoxide (see fig. 5.1). They were incubated air-free in a 
shaking incubator at 37°c for 20 min. After gaschromatographic 
analysis of these samples, a marked increase of 20a,22R-di-OH 
cholesterol and a decrease of the shaded area is shown (fig. 
5.2b). The indicated time at the abscissa has been corrected 
for the time it took CO to stop the reaction (tl-B= tl-A + 1 
min). 
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Fig. 5.3 (See legend on page 49) 
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Gaschromatographic separation on a packed column (3% SP-2250 
on chromosorb WHP, 100-120 mesh, length 1.8 m) of 200 ng each 
of the following trimethylsilylated steroids: 
1) pregnenolone, 2) epi-cholesterol, 3) cholesterol and 
4) 22R-OH cholesterol. Starting at 230°c, the oven temperature 
was programmed at 2°C/min to 280°C. The attenuation was 4 x 10. 
Fig. 5.4 
Gaschromatographic tracing of a sample taken from an incubation 
similar to the one described in fig. 5.2, 20 sec. after addi-
tion of 22R-OH cholesterol. Extraction, derivatisation, inter-
nal standard and gaschromatographic conditions are as described 
in fig. 5.3. Peak number 5 represents 20~,22R-di-OH cholesterol. 
Fig. 5.5 
Gaschromatographic tracing of a sample at t 5 min. 
Fig. 5.6 
Gaschromatographic tracing of a sample at t 7 min. 
Fig. 5.8 
Mass-spectra from synthetic 20~,22S-di-OH cholesterol and 
from the biological intermediate 20~,22R-di-OH cholesterol. 
Fig. 5.9 
Hypothetical scheme for the conversion of 22R-OH cholesterol 
into pregnenolone and isocaproaldehyde. 
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Fig. 5.7 shows a gaschromatogram obtained with a capillary 
column. The sample was taken at t=4 min. (fig. 5.2b) and 
injected together with a mixture of pregnenolone, epi-choles-
terol, cholesterol, 22R-OH cholesterol, 20a-OH cholesterol and 
20a,22S-di-OH cholesterol. The biological intermediate 20a, 
22R-di-OH cholesterol is clearly separated from the synthe-
tically prepared 20a,22S-di-OH cholesterol, while the mass-
spectra of both compounds are almost identical (fig. 5.8). 
5 6 7 
3 4 
120 MIN 90 60 
Fig. 5. 7 
Gas-liquid chromatography of trimethylsilylated steroids on 
a capillary column (see methods): 
1) 20a,22R di-OH cholesterol, 2) 20a,22S-di-OH cholesterol 
0 
3) 20a-OH cholesterol, 4) 22R-OH cholesterol, 5) cholesterol, 
6) epi-cholesterol, 7) pregnenolone. 
5.4 Discussion of the mass-spectra 
The upper part of fig~ 5.8 is the mass-spectrum of 
persilylated 20a,22S-di-OH cholesterol. The molecular weight 
of the compound is 634. Characterisation of some important 
fragments demonstrates the location of the hydroxylgroups 
in the side-chain. The fragment at m/e 563 indicates a 
simple fission of the 22-23 bond, and loss of an additional 
(CH,), Si-OH group produces a fragment at m/e 473. The peaks 
at m/e 461 (fragment I) and m/e 173 (fragment II) are due to 
fission of the 20-22 bond with the charge located on either 
the large or the small fragment (see insert of fig.5.8). 
The fragments at m/e 371 and m/e 281 are formed from fragment 
I by losing one or two (CH3)3 Si-OH groups respectively. 
Analogous to this fragment II will give a peak at m/e 83. 
The peak at m/e 117 could be explained by production of 
another small fragment by cleavage of the C17-20 bond in 
fragment I after hydrogen transfer from the steroid skeleton 
with the charge remaining at the C-20 site. Cleavage of the 
total side-chain is responsible for the fragment at m/e 289; 
it will also lose one (CH3)3 Si-OH group, yielding a peak at 
m/e 199. 
The lower mass-spectrum in fig. 5.8 is that of the biological 
intermediate and compares extremely well with the' upper 
spectrum. From these spectra and the gaschromatogram the 
conclusion is justified that the intermediate is 20a,22R-di-
OH cholesterol. The mass-spectrum is similar to the spectrum 
from the same compound isolated from meconium (Eneroth, 1969) 
with slight changes for the 20a-OH group. 
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5.5 Discussion 
According to the experiments described an intermediate 
between 22R-OH cholesterol and 20a,22R-di-OH cholesterol 
must be present when 22R-OH cholesterol is converted into 
pregnenolone and isocaproaldehyde. A peroxide as a physiolo-
gical intermediate is highly improbable. All tests on 
peroxides (Feigl, 1971; Stahl, 1967) indicated the presence 
of only traces of peroxides. In addition, the concentration 
of these trace amounts did not vary significantly in time. 
It has been suggested that in addition to 20a,22R-di-OH 
cholesterol two other intermediates {~ 20 -2 2 cholesterol and 
20,22-epoxy cholesterol) are involved in the side-chain 
cleaving mechanism of 22R-OH cholesterol (chapter 4). In 
fig. 5.2 it is shown that not all the intermediates of the 
reaction are detected by the method used. The possibility 
exists that one (or more) of the intermediates (i.e. 20,22-
epoxy cholesterol) is not extracted by ethylacetate. In 
addition, derivative formation of this intermediate may not 
yield a compound that can be detected by the gaschromato-
graphic method. A sample from the same incubation mixture, 
treated in a different way (exp. B), shows a relatively high 
amount of the intermediate 20a,22R-di-OH cholesterol. 
Moreover the apparent mass-defect is less than in experiment 
A. Apparently the incubation under 100% CO, and thus with 
complete inhibition of cytochrome P-450, is able to convert 
a compound, undetectable in experiment A, into 20a,22R-di-OH 
cholesterol. The reaction conditions preclude a conversion 
involving cytochrome P-450, NADPH or oxygen. This experiment 
may be explained by the involvement of an epoxyhydrase 
catalyzing the conversion of 20,22-epoxy cholesterol to 20a, 
22R-di-OH cholesterol (fig. 5.9). This enzyme requires a 
substrate and H2 0 to react and is not inhibited by carbon-
monoxide. Support of this hypothesis has been obtained from 
our studies describing the incubation of 22R-OH cholesterol 
in the presence of H2 18 0. The 18 o-label is incorporated in 
the intermediate 20a,22R-di-OH cholesterol (chapter 4), but 
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not in pregnenolone. The incorporation of a molecule H2 180 
into a dial suggests the involvement of an epoxyhydrase in 
the reaction. 
One might expect 20a-OH cholesterol to behave in a manner 
similar to 22R-OH cholesterol since conversion of the sterol 
in the presence of H2 18 0 gave rise to 18 0 containing pregne-
nolone (chapter 4). However, the phenomena shown in fig. 5.2 
have not been found with 20a-OH cholesterol as a substrate 
(unpublished experiments, R.J. Kraaipoel), probably because 
the conversion 20a + 6 20 - 22 is slower than 22R + 6 20 - 22 • 
The epoxyhydrase reaction therefore is no longer the rate 
limiting step. 
It is also possible to explain the different behaviour of 
20a-OH cholesterol and 22R-OH cholesterol with respect to 
the apparent "mass-defect" by postulating the formation of 
two different epoxides (20a,22a-epoxycholesterol and 20S,22B-
epoxycholesterol). This would support our earlier suggestion 
(chapter 4) that 6 20 - 22 cholesterol originating from 20a-OH 
cholesterol and 6 20 - 22 cholesterol originating from 22R-OH 
cholesterol are attached to the enzyme surface in stereo-
chemically different ways. 
Burstein et al. (1970b), using acetone extracted bovine 
adrenal cortex mitochondria, with recrystallisation techniques 
tentatively identified 20a,22R-di-OH cholesterol as an inter-
mediate. This has now been confirmed by our experiments, which 
are the first demonstration of the formation of the glycol 
from 22R-OH cholesterol by mass-spectrometry. The time course 
of the reaction described by Barstein et al. (1970b) and 
Burstein and Gut (1971), using this material, was similar to 
the one shown in fig. 5.2b but no "mass-defect" was found. 
An explanation for the discrepancy was suggested when we used 
mitochondrial preparations stored under poor conditions (the 
storage container was not refilled in time with liquid 
nitrogen). Under those conditions a conversion of 22R-OH 
cholesterol into pregnenolone according to fig. 5.2b was 
repeatedly demonstrated. We found earlier that the enzymic 
conversion of 20a,22R-di-OH cholesterol into pregnenolone and 
isocaproaldehyde is very susceptible to inhibition. Contact 
with air when mitochondria are in a freeze-dried condition 
also selectively damages this last step (chapter 4). The 
epoxyhydrase is no longer rate limiting and thus no epoxide 
but 20a,22R-di-OH cholesterol accumulates. This may be the 
reason why some investigators found 20a,22R-di-OH choles-
terol as an intermediate and others did not. 
It is tempting to speculate about the four enzymatic 
activities, that are involved in the conversion of cholesterol 
into pregnenolone. According to the scheme in chapter 4 this 
includes an oxidative desaturase (Fulco, 1974), an epoxidase, 
an epoxyhydrase and a lyase (desmolase). We suggest that the 
epoxidase and lyase activities belong to the group of cyto-
chromes P-450 (fig. 5.9). It is interesting to compare this 
with the cytochrome P-450 preparation isolated by Shikita 
and Hall (1973a,b), containing 8 heme groups per molecule 
P-450. It appears that this adrenocortical P-450 (mol. wt 
850.000) is isolated in a form consisting of 16 subunits and 
can exist in forms of 8 (mol. wt 470.000) and 4 (mol. wt 
200.000) subunits. Drastic treatment results in the formation 
of single units. The fragment of 4 subunits (after addition 
of. the. specific flavo-protein and non-heme iron protein} was 
still able to convert cholesterol into pregnenolone (Shikita 
and Hall, 1974). This clearly is an area that requires further 
research and elucidation. 
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1. Introduction 
It is generally accepted that 20o:,22R-di-OH choles-
terol (20a,22R)"' is an intennediate in the conversion 
of cholesterol into pregnenolone. There exist two 
main hypotheses concerning the biosynthesis of this 
intennediate in cholesterol side-chain cleavage, namely 
(a) a sequential hydroxylation of cholesterol and (b) 
a concerted attack of oxygen [1-6]. Both mechanisms 
imply that the two hydroxyl groups in the side-chain 
of20o:,22R contain oxygen atoms originating from 
molecular oxygen (Oz). 
In our previous communications [7 -9] it was sug-
gested that in the adrenal cortex cholesterol is con· 
verted into pregnenolone and isocaproaldehyde via 
the intenncdiates-A.Z 0 -z z cholesterol, 20.22-epoxy-
cholesterol and 20o:,22R. This epoxide-diol pathway 
implies that the side-chain of20o:,22R contains one 
oxygen atom originating from molecular oxygen (02 ) 
and another from water (Hz 0). 
ln this paper we will present evidence, obtained 
by GC-mass spectrometry and GC-mass fragmento· 
graphy, that supports our previously advanced hypoth-
esis. Since it is suggested that both cholesterol and 22R-
OH cholesterol are converted into pregnenolone via 
"Nomenclature and abbreviations: Cholesterol : 5-cholesten-
3,8-oL Epicholcsterol : S·cholestcn-3a-ol. 20a-OH cholesterol : 
S-cholcsten·3,8.20Cj-diol. 22R-OH cholesterol : (22R)-5·choles-
ten·3iJ,22-diol. 20a,22R-di~OH cholesterol : (22R)-5-cholesten-
3iJ,20a,22·triol. .1.,0 • 22 cholesterol: 5,20(22)-cholcstadien· 
3p-ol. 20.22-epoxycholesterol : 20.22-epoxy-5-cholcsten·3P· 
ol. Pregnenolone: S·prcgnen-3,8-ol-20-one. 
the same intennediates, the evidence for and against 
the r6le of 22R-OH cholesterol as an intennediate 
in the side-chain cleavage of cholesterol is discussed. 
2. Materials and methods 
The conversion of cholesterol into pregnenolone 
and isocaproaldehyde in the presence of IS-oxygen 
enriched water (Hz 18 0) was essentially carried out 
as described before [8}. Freeze-dried bovine adrenal 
cortex mitochondria (26 mg protein, estimated by 
the biuret method) were added to the incubation 
medium containing 50% H2 18 0. Cholesterol, 600 f.lg 
(-= 1.56 ,umol) dissolved in 0.1 m1 acetone, was added 
to the reaction mixture. The fmal vol was 4.2 ml. 
Caproaldehyde, 100 ,ug (-= 1.0 ,umol) dissolved in 0.01 
ml ethanol, was added to the reaction mixture and the 
conversion was started by the addition of a NADPH-
generating system [8]. 
After 30 min. incubation at 37°C with continuous 
stirring the reaction mixture was divided into three 
equal parts. Each of these was added to 3 m1 pentane-
ether (I: I, vfv). Epicholesterol (100 ,ug/rnl) was added 
as an internal standard. The wat'er layer was made 
alkaline (pH 8) with sodium bicarbonate and was 
extracted three times. The combined organic layers 
contained the sterol fraction. The water layer was 
acidified (pH 2) with Hz S04 and isocaproic acid and 
caproic acid were extracted. The pentane-ether ex-
tract containing the acids was concentrated by evapo-
ration under nitrogen. Gas chromatographic analysis 
was perfonned on a Varian 2100 instrument, equipped 
North-Holland Publishing Company- Amsterdam 
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with a flame ionisation detector. The stainless steel 
column (length 2m, i.d. 3.5 mm) was packed with 
Chromosorb WHP, coated with 25% DEGA. 2% H3 P04 • 
The temperature of the injector was 160°C, of the oven 
145°C and of the detector 190°C. Nitrogen was used 
as the carrier gns. Retention times of isocaproic acid 
and caproic acid were 10 and 12 min respectively. 
Under these conditions caproaldchydc was located 
in the solvent peak. 
The extract containing the sterol fraction was evapo-
rated under nitrogen and derivatiscd with trimcthyl-
silylimidazole and analysed by gas chromatography 
[8]. The sterols were quantified by comparison of 
the areas of their GC-peaks with the area of that of 
epicholesterol. 18 0-incorporation into pregnenolone 
was measured by GC-mass spectrometry [SJ, using a 
Finnigan 10150-6000 MS-computcr system. 18 Q.. 
incorporation into 22R-OH cholesterol. 20a.22R. 
isocnproic acid and caproic acid was measured by 
GC-mass fragmentography [!OJ. using the S.."tme 
instrument. In this technique the mass spectrometer 
functions as a specific detector for the gas chroma to· 
graph. The areas of the GC-pcaks of the fragment ions 
A and A+ 2 were calculated by computer. Incorpora-
tion of 18 0 into fragment A should increase the area 
of the ion A+ 2 with respect to the area of fragment 
A. 
GC conditions used in combination wtih MS were 
similar to the conditions described above but helium 
was used as the carrier gas. 
3. Results and discussion 
Bovine adrenal cortex mitochondria {with endo-
geneous and exogeneous cholesterol as a substrate) 
were incubated in the presence of 50% Hz 18 0 as 
described in the methods. After 30 min at 37°C the 
sterols were extracted from the incubation medium 
and analysed by gas chromatography. The gas chromato-
gram of the persilylated sterol fraction revealed peaks 
with retention times of pregnenolone (11 0 11g). epi-
cholcsterol, cholesterol. 22R-OH cholesterol (Sp.g) 
and 20o:,22R (2 p.g). The identity of these compounds 
was confirmed by comparing their mass spectra with 
the mass spectra of the authentic compounds. Further-
more 18 0-incorporation from H~ 18 0 into pregnenolone, 
22R-OH cholesterol, "0o:,22R, isocaproic acid and cap· 
roic acid was measured. 
3.1. 20a,22R-di-OH cltulesterol 
The mass spectrum of persilylatcd 20o:.22R ob-
tained from the incubation described above was simi-
lar to the one recently described [9]. In order to 
measure 18 0-incorporation into the hydroxyl groups 
of the side-chain of 20o:,22R, two fragment ions from 
the mass spectrum were chosen. Fig. I shows that 
the C-8 fragment gives rise to m/e 289. This fragment 
ion contains both hydroxyl groups of the side-chain 
of20a,22R. Cleavage between C~0 and C~z results in 
the formation of a fragment ion at m/e 461. This C-21 
fragment contained only one hydroxyl group attached 
to C~0 of the steroid skeleton. In order to measure 18 0-
incorporation into these fragments a gas chromatogram 
was made with monitoring of the fr:.Jgment ions at m/c 
289, 291, 461 and 463. The intensities of the ions at 
m/e 289 and at m/e 461, calculated from the areas 
under their GC-pcaks. were arbitrarily taken as I 00. 
Table 1 shows that in the experiment performed in 
the presence of H2 18 0 there was a marked increusc 
in the abundance of the ion at m/e 291 compared to 
that of the same fragment ion obtained in the presence 
of H~ 16 0. In CQntrust to this the abundance of the 
fragment ion at m/e 463 (C-21 fragment) did nQt 
change in the presence or absence of H~ liS 0. From 
these results it was concluded that incorporation of 
18 0 from H~ 11\0 is restricted to the hydroxyl group 
attached to C22 • This incorporation of water into a 
vicinal diol strongly supports the concept of an epo-
xide-diol pathway. The epoxy-hydrase catalysing 
TMSO 
20cx,22R-di-0H CHOLESTEROL 
fi)!.l. The trimcthylsilyl d<:riv;1tiw ui" 20o.,12R·di-OH L'ilol· 
estero!. The C'-8 fwgrnent a1 m/e 2R9 ~nd the' C'-21 fru)!.mc•nt 
~~ m/c 461 :1r<: indic:ncd. 
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'~0-Incorporation into the compounds above, isolated from the H~ '~0-
containing incub:ltions, was measured by GC-mass fragmentography 
Compound m/o m/o m/c m/c 
20.:::..22R 461 463 289 291 
H~ '60 100 J 1.6 
H:'30 100 11.7 
100 8.5 
100 52.8a 
22R-0!-l cholesterol !73 175 
H:'"O 100 2o.ob 
H2 '~o 100 21.1 b 
Pregnenolone 298 300 388 390 
H:'6Q 100 3.0 100 7.2 
H,'"O 100 4.0 100 8.0 
lsoc:~proic acid 60 62 64 
Hz'"O 100 0.7 0.0 
H2 '"0 100 72.4 16.3 
Caprok acid 60 62 64 
H2 ' 6 0 100 0.7 0.0 
H2 '~o 100 72.8 21.7 
Control values were obtained from similar experiments in the presence of 
Hz 16 0. except for 20cd2R which was biosynthesised [9]. 
:l The percentage incorporation of Hz 0 from the medium w.~s calcul:Jted 
as follows: 
52.8- 8.5 100 JOO'i~ ~ 60% 
100 + (52.8- 8.5) 50 . 
b The high abundance of the ion 175 is due to other fragmt:nts adding to 
the :.~bundancc of the isotope fragment. 
this reaction selectively opens 20,22-epoxycholesterol 
in such. way· that the oxygen atom from the epoxide 
is transferred to the hydroxyl group attached to C20 
from 20a:.22R. As shown above, the oxygen atom 
from water will be transferred to the hydroxyl group 
attached to C22 from 20a:,22R. 
The enzymic formation of an epoxidc requires 
both an epoxidase and a substrate containing a double 
bond (A20 -:: 2 cholesterol). In addition to this NADPH 
and 0 2 are required [9J. We therefore suggest that 
cholesterol is converted into pregnenolone and iso-
caproaldehyde via A20 - 22 cholesterol, 20,22-epoxy-
cholesterol and 20a,22R. 
From our results (table 1) it can be calculated that 
60% of 20a,22R is formed with water from the H2 18 0-
containing medium. Therefore 40% is formed with 
water from another source. Side-chain cleavage of 
cholesterol requires 3 mol NADPH +Wand 3 mol 0 2 
[II]. Besides pregnenolone and isocaproaldehyde, 3 
mol NADP* and 5 mol H2 0 are formed. The conver· 
sion of20,22-epoxycholesterol into 20a:,22R, catalysed 
by an epoxy-hydrase, requires 1 mol H2 0. The net 
water production of cholesterol side-chain cleavage 
therefore is 4 mol H2 0. The finding that only 60% of 
20a:,22R is synthesised with water from the medium 
indicates that only a limited exchange exists between 
water formed during the side-chain cleavage of chol-
esterol and water from the H2 18 0 containing medium. 
As a result of this 40% of 20a,22R is synthesised with 
water that has been formed by the side-chain cleavage 
reaction. 
If one calculates the 18 0-content of the two hydro-
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xyl groups attached to C20 and C22 of 20a:,22R (as-
suming the experiment was carried out in the presence 
of 100% H2 18 0) one fmds 0% (C20 ) and 60% (C"l::) 
resulting in a mean content of 30%. On calculating 
the 160-content of the two hydroxyl groups one fmds 
.100% (C20 ) and 40% (C22 ) giving a mean content 70%. 
The oxygen atom attached to C20 originated from 
20,22-epoxycholesterol. The epoxide in its tum was 
fanned from A22 -:n cholesterol with molecular oxy-
gen ('6 0::). The oxygen atom attached to c"l"l origi-
nated from water. As shown above 40% of the water 
used in the biosynthesis of 20o:,22R has been fanned 
as a product of the cholesterol side-chain cleavage 
reaction. This water will be H2 16 0. 
Assuming this experiment was carried out with 
water (H2 16 0) and IS-labeled molecular oxygen (1 00% 
180:!) the same calculations would result in 30% 16 0-
content and 70% 18 0-content. 
Recently Burstein et al. [12] described an experi-
ment in which [14 C} cholesterol was incubated with 
an acetone powder of bovine adrenal cortex mito-
chondria in the presence Of 180 2• They reported a 
68% incorporation (mean content) of 18 0 in the two 
hydroxyl groups of the side-chain of [14 C] 20a:,22R. 
Their result agrees nicely with our calculated 70%. 
When they doubled the amount of glucose 6-phosphate 
dehydrogenase the incorporation of 18 0 into the side-
chain increased up to 90.5%. Apparently a NADPH-
oxidase not tightly coupled to the side--chain cleavage 
reaction increases the endogenous production of H2 180. 
The hypothesis that the vicinal dial (20o:,22R) is 
form~d as a result of the reaction of an epoxide (20, 
22-epoxycholesterol) with water is supported by both 
our experiments and those of Burstein et al. { 12] . 
The suggestion [ 12] that cholesterol is converted 
into 20a:,22R by the concerted attack of separate 
molecules of oxygen must be rejected. 
3.2. 22R-OH cholesterol 
The mass spectrum of the trimethylsilyl derivative 
of 22R-OH cholesterol showed a fragment ion at m/e 
173, due to fission between C20 and C22 • The side-
chain, containing the trimethylsilyl group at c22' is 
present as a fragment ion. Moreover this ion at m/e 
173 was the most abundant ion from the mass spec-
trum. Incorporation of 18 0" into the hydroxyl group 
attached to C22 is expected to give an increase of 
the abundance of the ion at m/e 175.ln order to 
measure 18 0 incorporation into 22R-OH cholesterol 
a gas chromatogram was made while the fragment 
i.ons at m/e 173 and 175 were monitored. Table 1 
shows that only a negligible difference existed between 
the abundance of the ion at m/e 175 from either syn· 
thetic 22R-OH cholesterol or the same compound 
fanned from cholesterol in the presence of H2 18 0. 
From these data we conclude that no incorporation 
of 18 0 from H2 18 0 into 22R-OH cholesterol took 
place. 
Recently it was reported [13} that incubation of 
e 4 C] cholesterol with an acetone powder of bovine 
Table 2 
60 
Summary of the labeling studies performed with ' 8 0 3 and H2 18 0 
Substrate 
Cholesterol 
22R-OH cholesterol 
20a-OH cholesterol 
20o:,22R-di-OH cholesterol 
22R..QH 
cholesterol 
1302 H2uo 
+' 
20a.22R-di-0H cholesterol 
C~0 C~2 
Lao2 H2 uo lBQ2 H:'" 
+b 
-
b + 
= 
d 
nm +d 
= = nm nm 
Pregnenolone 
Lao1 H1 •no 
+' 
-
+' 
-
d 
- ' 
+ 
- ' 
nm 
Incorporation of u 0 into the side-chain of 20o:,22R is expressed separately for the hydroxyl groups attached 
to C10 and C:n. (:1') nO-incorporation.(-) No 1"0-incorporation. {nm) Not measured. 
a Burstein et al. [ 131 , 
b See comments on the results of Burstein et al. [12], in this paper, 
c Takemoto et al. (17]. 
d Kraaipoel et at. [8] • Nakano et al. [18 1 . 
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'(V'<---=~ 
o~~~~2:~m p~~~~~s~ l CHOLESTEROL CHOLESTEROL 
EPOXIDE HYPOTHESIS A 
~~~ 
Q____.,p~~ 
! CHOLESTEROL 
EPOXIOE HYPOTHESIS B 
Fig.2. Two hypotheses for the convers-ion of cholesterol into A ~0 _,2 cholesterol. 
adrenal cortex mitochondria in the presence of 18 0 2 
resulted in the formation of 18 0-incorporated P4 C) 
22R-OH cholesterol. We suggest that both cholesterol 
and 22R-OH cholesterol [9] are converted into preg-
nenolone and isocaproaldchyde via 6 20- 22 cholesterol, 
20,22-epoxycholesterol and 20o::,22R. Moreover both 
substrates in the presence of H2 180 are converted into 
20Q,22R with 180 attached to C22 (table 2). Therefore 
it ntight be concluded that 22R-OH cholesterol is an 
intermediate in the conversion of cholesterol into 
6 20 -:n cholesterol (Hypothesis B; fig.2). However other 
experiments suggest that cholesterol is converted directly 
into 6 20 - 22 cholesterol (Hypothesis A). On closer 
examination of both these hypotheses one must make 
additional assumptions. 
Hypothesis A 
cholesterol desaturase 6 20 - 22 cholesterol 
(de )hydratase 
____.. 22R-OH cholesterol. 
Thus 22R-OH cholesterol would be formed by the 
reaction of 8 20 - 22 cholesterol with water. Our 
experiments show that water from the H2 180 
containing medium was not used. Therefore the 
assumption has to be made that water formed by the 
desaturase reaction is retained by the enzyme system 
and transferred to 22R.QH cholesterol without 
exchange with water from the medium. 
298 
Hypothesis B 
cholesterol mono-oxygenase:> 22R-OH choleSterol 
{de)hydratase 
~ 8 20 - 22 cholesterol. 
The studies of Hochberg et al. [I 4) show that a 
cholesterol analog {20S)-20{p-Tolyl)-5-pregnen-3,6-ol 
is converted into a 20-hydroxyl derivative, which is 
further converted into pregnenolone. In order to 
explain these results in terms of Hypothesis B one 
must assume that the 22R-mono-oxygenase is non-
specific and therefore also can act as a 20-mono-
oxygenase. 
(205)-20 (p-Tolyl)-5-pregnen-3~-ol [14], 23,24-
di-nor-chol-5-en-3,6-ol [15}, and 25-0H cholesterol [16] 
can all be converted to their 20-hydroxy-derivatives 
and can also be converted into pregnenolone. How· 
ever the formation of these 20-hydroxylated com-
pounds can also be explained by a desaturase reac-
tion followed by a hydratase reaction {Hypothesis A). 
The calculations made by Bustein et al. [ 6] Jed 
them to the conclusion that the pathways via the 
mono-hydroxylated sterols contributed only a small 
part to pregnenolone formation from cholesterol and 
that the most important pathway consisted of a 
direct conversion of cholesterol into 20a,22R Very 
recently [13] these authors however have drastically 
altered the interpretation of their experiments. 
We believe the current experimental evidence does 
61 
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not permit one to distinguish which of these two 
mechnnisms is correct. 
3.3. Pregnenulune 
From table I it can be seen that no 18 0 has been 
incorporated into pregnenolone formed by cholesterol 
side-chain cleavage in the presence of Hz 18 0. This 
result is consistent with the finding that no H>o. 
labeling occurred at C20 of20o:.22R. Table 2 shows 
that cholesterol in the presence of 111 0 2 is converted 
into 18 0-labelcd pregnenolone [17]. 
3.4. (!so)caproaldehyde and (iso)caproic acid 
Freeze-dried bovine adrenal cortex mitochondria 
arc able to convert both isocaproaldchydc and capro-
aldehyde into their acids. Incubation of I 00 JJ-g (1.0 
jJmol) caproaldehyde for 20 min at 3T'C in a medium 
(sec Methods) containing denaturated mitochondrb 
(3 min at 95°C), or a similar incubation in medium 
alone resulted in a 15% conversion of caproaldehyde 
into acid. Also addition of the same aldehyde to a 
pentane-ether-water mixture, followed by the 
extraction procedure (sec Methods) gave a similar 
conversion ( 15%). Considering the oxidative capacity 
of the freeze-dried bovine adrenal cortex mitochondria, 
one might expect the isocaproaldehyde formed by 
cholesterol side-chain cleavage to be converted into 
isocaproic acid. The time course of the formation of 
pregnenolone and isocaproic acid was followed by 
taking samples every 2"0 min (fig.3). The results of 
this experiment show a stoichiometric relationship 
between pregnenolone and isocaproic acid. It was 
concluded that all the cnpronldehydc formed in the 
side-chain cleavage reaction by damaged mitochondria 
is transformed into acid. 
Incorporation of Hz tt> 0 into 20o:,22R with the IS· 
oxygen atom attached to the C:n makes it plausible 
that the IS-oxygen atom was transferred to isocapro-
aldehyde and isocaproic acid. However oxygen atoms 
from aldehydes and acids arc exchangeable with the 
same atoms from water. Incorporation can be measured 
if such an exchnnge is slow. Caproaldehydc was there-
fore added as an internal standard, and oxidation of 
this aldehyde to isocuproic acid provided a control for 
oxygen exchange. The mass spectra of both isocaproic 
and caproic acid present an abundant fragment at m(e 
60 {CH2 =C(0Hh}, containing both oxygen atoms 
from the acids. The intensity of m(e 60, calculated 
62 
nmol 
350 
300 
250 
200 
"0 
' 
"0 
50 
0 
0 
" 
' 
' 
' 
' 
' 
20 30 
CD--
o- - -o I$0CAJ>ROIC ACTO 
- I'RtCNCNO~ONE 
40 50 60 MIN 
Fif:.3. Frc•czc·<lrkd bovine aJrcn:~l <.'<Ht<::-. mitodwndrb (30 
mt:: protdn). St!pporteJ by~ :o.;ADf'll-t::,_;on..:r:~tin)! ~ystcm, con-
vert~·<.! chok~tcr<ll into prct:nc·nolonc and isucaprui<: acid (sec 
!llctiHlds). l:pkholcst.:rull 20 1-'b/miJ :~nJ c:~proic a.:id ( 10 1-'!!/ 
ml) wen: :1dded as int.:rnal ~t:1nd:~rd~. Bnth prc)!.ncnulone and 
isoc·aprok add wen• ~~tim:1t<:d by )!:.IS <.:hrom:i\ll):faphy. 
from the area under the GC-pe::tk of the ion at m(e 60. 
was arbitrarily tJken as I 00. The t"ragmcnt ions at m/e 
62 nnd at m(e 64 (two 111 0 atoms incorporated) were 
monitored at the same time. The observations shown in 
t::Jble I clearly indicate the existence of an exchange be-
tween 18 0 from H~ 180 and the oxygen atoms from the 
internal standard caproic acid. Equilibrium has almost 
been nearly reached in respect to the tll 0-cnrichmcnt 
of both the water from the medium and caproic acid. 
Therefore it is not possible in this way to measure 1 ~0 
tr::tnsfer from 20o:,2:!R to ism::aproic a~id. 
Combining all the experiments ~arried out in the 
presence of ll>o: and fl 2 1 "~0 it ~an he seen fn.1m table 
2 that the results arc complementary. tHO-im:orpora-
tion from Hz 18 0 into the common intenncUiate 20a:, 
22R is the same for both cholesterol and 22R-OH 
cholesterol. The reverse holds for ::!Oet-OH cholesterol 
and so it cannot bt:: considered as an int~rmediatc in 
cholesterol side-chain clt::avagc. 
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CHAPTER 7. 
STOICHIOMETRY OF THE ADRENOCORTICAL SIDE-CHAIN CLEAVAGE 
REACTION, 22R-OH CHOLESTEROL INTO PREGNENOLONE, ESTIMATED 
WITH RESPECT TO OXYGEN 
7.1 Introduction 
The stoichiometry of the side-chain cleavage of cholesterol, 
20~-0H cholesterol and 20a,22R-di-OH cholesterol has been 
previously examined with respect to oxygen by Shikita and Hall 
(1974). In our opinion it is highly questionable if 20a-OH 
cholesterol is an essential intermediate in cholesterol side-
chain cleavage (chapter 6). A more likely candidate is 22R-OH 
cholesterol. We therefore have estimated the stoichiometric 
relationship between oxygen and side-chain cleavage of 22R-OH 
cholesterol. In addition, we have estimated the oxygen 
requirement of 20a-OH cholesterol conversion for comparison 
of our results with those of Shikita and Hall {1974). 
7.2 Materials and methods 
7.2a Preparation of the mitochondrial fraction 
Bovine adrenals were obtained from the local slaughterhouse 
and transported on ice to the laboratory within 30-45 min. 
After removal of the medulla and the capsule, a 10% (w/v) 
homogenate of the cortex in 250 mM sucrose, 10 mM Hepes {pH 
7.35) and 0.5 mM EGTA was prepared by the use of a Potter-
Elvehjem homogenizer with a power-driven teflon pestle. 
Mitochondria were isolated from the supernantant of a 800 g 
10 min spin by centrifugation at 9000 g for 10 min. The mito-
chondrial pellet was washed twice by resuspending in the 
isolation medium and resedimenting at 10.000 g for 10 min. 
The final pellet was suspended at a protein concentration of 
30 rng/ml. The respiratory control rations with succinate were 
2-3. The whole isolation procedure 't·Tas performed at 4 °C in a 
cold room. 
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7~2b Estimation of the stoichiometry 
The oxygen consumption corresponding with the side-chain 
cleavage of the steroid-substrates was measured with an oxygen 
electrode in a magnetically stirred vessel, at 37°C. The 
oxygen concentration of the incubation medium at 37°C 
saturated with air was calculated as described by Chappell 
(1964). Intact bovine adrenal cortex mitochondria (0.63 mg) 
were suspended in a medium containing: 100 rnM sucrose, 40 rnM 
KCl, 10 mM potassium-phosphate buffer, 20 mM Hepes-buffer 
pH 7.35, 1 mM EGTA, 1% bovine serum albumin, 4 mM NaNs, 2 ~g/ 
ml cyanoketone, 0.5 ~g/ml oligomycine and 10 ~~ succinate. One 
minute after the addition of the mitochondria 2 ~g/ml anti-
mycine was added, followed by 10 mM malate. After 6 min 
incubation 22R-OH cholesterol or 20et.-OH cholesterol (SO nmol; 
yielding a concentration of 34.5 ~M) was added. The final 
volume was 1.45 ml. 
Conversion of steroid-substrates and the formation of 
intermediates and products were measured in a parallel 
incubation experiment, using the same medium, but with a final 
volume of 30 ml. Every 30 sec a sample of 1 ml was taken and 
added to 6 ml cold ethylacetate. Before the addition of the 
steroid-substrate a sample was taken to correct for the 
pregnenolone production from endogenous cholesterol. 35 ~M 
epi-cholesterol was added to the sample as an internal standard. 
Steroids were extracted with 3 x 6 ml distilled ethylacetate. 
The solvent was evaporated at room temperature under nitrogen. 
The extract was silylated with N-trimethylsilylimidazole by 
heating at 100°C for one hour in the presence of dry pyridine 
hydrochloride. The analytical separations were carried out by 
gaschromatography as described in chapter 4. Peak areas and 
retention times were calculated by a Hewlett-Packard 21 MX 
computer. The stoichiometry of the reactions was calculated 
from the rate of oxygen consumption and the rate of pregneno-
lone production. 
65 
7~3 Results 
7.3a Estimation of the stoichiometry of the side-chain 
cleavage reaction with respect to oxygen 
22R-OH cholesterol 
The conversion of 22R-OH cholesterol by intact mitochondria 
was complete within 6 min (fig. 7.1). Only a small amount of 
the intermediate 20a,22R-OH cholesterol could be detected. Its 
ident-.ity was confirmed by GLC-mass-spectrometry (see chapter 5). 
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Fig. 7.1 
Conversion of 50 nmol (34 f.lM) 22R-OH cholesterol via 20a,22R-
di-OH cholesterol into pregnenolone by intact bovine adrenal 
cortex mitochondria. Oxygen consumption was measured with an 
Oz-electrode; final volume 1,45 ml. Steroids and sterols were 
estimated in samples taken from a parallel-incubation (see 
7.2b) and quantitated by gas-liquid chromatography. 
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ParalleJ to '~his incubation in a large volume, an incuba-
tion wa~ p·, r for:med at the same time in an oxygraph with a 
volume r··t l.45 ml. It is shown in fig. 7.1 that 48 nmol 
22R-OH cholesterol is converted into 46 nmol pregnenolone 
with the consumption of 96 nmol oxygen. The stoichiometry 
was calculated by taking the ratio of 75 nmol oxygen 
consumed/5 min and 36.5 nmoles pregnenolone produced/ 5 min. 
This resulted in a stoichiometry: 2.06. After completion of 
the reactions, catalase was added to the oxygraph to detect 
any H20 2 formed. There was, however, no increase of the 
oxygen concentration in the incubation vessel after addition 
of catalase. 
The oxidation of isocaproaldehyde (a product of the side-
chain cleavage) to isocaproic acid might also consume oxygen. 
Therefore isocaproaldehyde was added to the incubation vessel. 
The addition of various concentrations of this aldehyde to the 
intact mitochondria in the oxygraph did not result in a 
measurable oxygen consumption. As further metabolism of 
pregnenolone and therefore the oxygen consumption required for 
these reactions were inhibited by cyanoketone (Goldman, 1967) 
it can be stated that 2 mol oxygen are required to convert 
1 mol 22R-OH cholesterol into 1 mol pregnenolone and 1 mol 
isocaproaldehyde. Three additional experiments resulted in a 
stoichiometry of 1.90, 1.99 and 2.05. 
20a-OH cholesterol 
Intact bovine adrenal mitochondria from the same batch 
converted 20a-OH cholesterol into pregnenolone within 12 min 
(fig. 7.2). Similar control experiments as described for 
22R-OH cholesterol were performed. The amount of pregnenolone 
formed by the cleavage reaction was only 60% of the expected 
amount and in addition to the interr.:tediate 20a,22R-di-OH 
cholesterol another compound, tentatively identified as 
20a,25-di-OH cholesterol, was formed during the reaction. The 
mass-spectrum of this compound is shown in fig. 7.3. The 
formation of by-products precluded an exact calculation of 
the stoichiometry with respect to oxygen. The estimated 
stoichiometry, obtained from the lineair parts of the curves 
shown in fig. 7.2 ( t = 0 tot= 5 min), was 2.6. 
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Conversion of 50 nmol (43 f.IM) 20CX-OH cholesterol into 
pregnenolone. Both 20a,22R-di-OH cholesterol and 20a,25-di-
OH cholesterol (tentatively identified) w~re formed during 
the reaction. The reaction conditions were similar to those 
described for fig. 7.1. 
68 
PERCENTAGE OF 
SASE PEAK 
100 
80 
60 
40 
73 
117 
143 
" 109 
289 
20 131 
0 
50 100 150 200 250 
Fig. 7. 3 
Mass-spectrum of the compound detected in the experiment 
shown in fig. 7.2. 
The compound was tentatively identified as 20a,25-di-OH 
cholesterol. 
7.4 Discussion 
7.4a Discussion of the mass-spectrum of 20a,25-di-OH 
cholesterol 
I 
I 
"' 
I ~ 1450 M/E 
The mass-spectrum of the compound detected showed some 
resemblance with the previously reported spectrum of 20a, 
22R-di-OH cholesterol (chapter 5). Although no molecular ion 
was recorded, the fragments with m/e 461 and m/e 117 and also 
m/e 289 and m/e 199 indicate the presence of a side-chain 
with two hydroxylgroups. The location of one of these hydroxyl-
groups is evident as a 20a-OH group from the fragments 461 
and 117. 
The location of the second group is found from a fragment 
at 131 arnu, indicating a cleavage between Cz4 and Czs- The 
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same fragment was also observed in the mass spectrum of 25-
0H cholf~sterol. From these data the compound was tentatively 
identified as 20a,25-di-OH cholesterol. 
7.4b Discussion of the stoichiometry 
A stoichiometric relationship \·Tith respect to oxygen has 
hven calculated for cholesterol, 20cx-OH cholesterol and 20cx, 
22R-di-OH cholesterol (Shikita and Hall, 1974). These sub-
strates required 3,2 and 1 mol oxygen respectively for 
conversion into pregnenolone and isocaproaldehyde. According 
to the experiment shown in fig. 7.1, 1 mol 22R-OH cholesterol 
required 2 mol oxygen (02) for conversion into pregnenolone 
and isocaproaldehyde. The estimated stoichiometry fitted both 
the classical scheme of cholesterol side-chain cleavage (22R-
OH cholesterol, 20a,22R-di-OH cholesterol, pregnenolone) and 
the epoxide-diol hypothesis (22R-OH ~holesterol, 6 20 - 22 cho-
lesterol, 20,22-epoxy-cholesterol, 20a,22R-di-OH cholesterol, 
pregnenolone). 
In fig. 7.2 it can be seen that using intact bovine adrenal 
cortex mitochondria, an unequivalent amount of pregnenolone 
was formed from 20a-OH cholesterol. Apparently other enzymatic 
activities (i.e. ~ 25-hydroxylase) were present in the 
mitochondrial preparation (Bosisio et al. 1976). Using purified 
cytochrome P-450scc (Shikita and Hall, 1974) 20a-OH cholesterol 
was converted into an equivalent amount of pregnenolone. In 
this way the formation of 1 mol pregnenolone required 2.1 ± 
0.3 mol oxygen. The advantage of using purified cytochrome 
P-450scc is evident; no other products than pregnenolone are 
formed and a more exact stoichiometry can be calculated. 
However, a disadvantage of using purified P-450scc is the high 
background consumption of oxygen and NADPH not coupled to 
the side-chain cleavage reaction. The high background oxygen 
consumption decreases the accuracy of the calculated stoichio-
metry. 
Using intact bovine adrenal cortex mitochondria the 
formation of both pregnenolone and possibly 20a,25-di-OH 
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cholesterol from 20~-0H cholesterol precluded an exact 
calculation of the stoichiometry. However, the relative fast 
conversion of 22R-OH cholesterol, the low background oxygen 
consumption and the nearly equivalent amount of pregnenolone 
formed, allowed us to calculate a stoichiometry with respect 
to oxygen. 
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CHAPTER 8 
THE EFFECTS OF AMINOGLUTETHIMIDE PHOSPHATE ON THE CHOLESTEROL 
SIDE-CHAIN CLEAVING SYSTEM IN BOVINE ADRENAL MITOCHONDRIA 
8.1 Introduction 
Arninoglutethimide phosphate (AGI) is a well-known inhibitor 
of steroidogenesis in adrenals, ovaries and testes (Gower, 
1974). AGI can inhibit pregnenolone formation from cholesterol 
by adrenal preparations in vitro (Kahnt and Neher, 1966). After 
administration of AGI in vivo a syndrome resembling congenital 
lipoid adrenal hyperplasia has been reported (Goldman, 1970, 
Prader and Siebenman, 1957). 
Initially it was thought that AGI inhibited the first 
enzymic step of the cholesterol side-chain cleaving system, the 
conversion of cholesterol into 20a-OH cholesterol (Kahnt and 
Neher, 1966). More recently, it has been suggested that AGI 
inhibits the side-chain cleavage of cholesterol at the site of 
cytochrome P~450scc reduction (Mcintosh and Salhanick, 1969). 
This suggestion has been supported by Bell and Harding (1974) 
who reported that AGI inhibited cholesterol side-chain cleavage 
non-competitively. 
Evidence for another mechanism of inhibition was found by 
Paul et al. (1976) who reported that AGI inhibited the (ACTH 
induced) formation of an enzyme-substrate complex between 
cholesterol and cytochrome P-450scc· 
In this chapter we will describe the effects of AGI on 
a) pregnenolone formation from several possible intermediates 
of cholesterol side-chain cleavage, 
b) the rate of cytochrome P-450scc reduction in the presence of 
several sterols and 
c) the pH-dependent formation of an enzyme-substrate complex 
between cholesterol and cytochrome P-450scc· 
For details about Type I, reverse Type I and Type II spectra, 
the reader is referred to the appendix of chapter 8. 
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8.2 Materials and methods 
8.2a Preparation of the mitochondrial fraction 
Mitochondria were prepared as described in chapter 7. 
Damaged mitochondria were prepared by suspending the intact 
mitochondria for 5 minutes in distilled water. After 
centrifugation for 10 minutes at 10.000 x g the mitochondrial 
pellet was suspended in 250 mM sucrose and this suspension was 
stored in liquid nitrogen. 
8.2b Estimation of pregnenolone production and oxygen 
consumption 
The rate of the side-chain cleavage reactions and the 
corresponding oxygen consumption were measured as reported in 
chapter 7. 
8.2c Estimation of V and Km 
The integrated form of the Michaelis-Menten equation~ was 
used. This equation can, using initial condition: 
S = 8 0 at time ~ 0, 
be written as: 
Km ln (S/80 ) + S - S0 + V.t = 0. 
Using standard mathematical techniques for the calculation 
of the least square fit and the set of experimental data 
(si, ti), explicit expressions for V and Km are obtained in 
case S0 is known. In case S0 is not known a simple extension 
of the procedure is sufficient to obtain s 0 (Cornish-Bowden, 
1976). 
v.s 
XThe Michaelis-Menten equation is: v = dS/dt 
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8.2d Kinetics of NADPH supported cytochrome P-450 reduction 
The rate of the NADPH-supported cytochrome P-450 reduction 
was assayed as described by Gigon et al. (1969). Damaged 
mitochondria, equivalent to 3 mg protein, were suspended in 
2.5 ml of the medium described in the legend of figure 7.2. 
In order to remove traces of oxygen, the N2 over the reaction 
medium was first bubbled through an alkaline dithionite 
solution. A stopcock-plunger assembly provided with 50 ~1 of 
NADPH-solution (final concentration 0.4 mM) was fitted to the 
cuvette and CO was led over the suspension for one additional 
minute. Then the cuvette was closed and placed into an Aminco 
DW-2 UV-VIS spectrophotometer, used in the dual wavelength 
mode. The cuvette was kept at 30°C and a baseline absorbance 
was recorded. After one minute the plunger was quickly de-
pressed and (E450 nm - E490 nml was recorded (chart speed of 
2 inch/sec). The initial rate of reduction was estimated by 
determining the change in (E450 nm - E490 nm) during the first 
1,5 sec after mixing. The rate was expressed as nmol cytochrome 
P-450 reduced/min/mg protein using 91 cm- 1 • mM- 1 as the value 
of the absorption coefficient (Omura and Sate, 1963). The 
total amount of cytochrome P-450 present was determined by 
adding a few crystals of sodium dithionite to the cuvette and 
allowing the reaction to proceed for about one minute to 
obtain at least 99% reduction. 
Bovine adrenal cortex mitochondria contain at least three 
different cytochrornes P-450 respectively for cholesterol side-
chain cleavage, 11S-hydroxylation and 18-hydroxylation. These 
cytochromes contribute to the estimated rate of cytochrome 
P-450 reduction. 
8.2e Estimation of the pH dependent change in spin-state 
Damaged mitochondria were added to a medium containing 
125 mM sucrose, 50 mM phosphate buffer and 50 mM Tris-HCl 
buffer (pH 6.40). The difference spectra were recorded on a 
Shimadzu double beam spectrophotometer, slit 2 nm. The 
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suspension was divided equally over two cuvettes and a base 
line of constant absorbance was obtained. Both cuvettes 
contained mitochondria equivalent to 0.45 mg protein/ml. A 
difference spectrum was obtained by adding aminoglutethimide 
phosphate to the sample cuvette (final concentration 400 ~M). 
The extinction difference between 390 and 410 nm was calculated 
from the difference spectrum. Full scale of the recorder was 
0.1 E. pH-induced changes in the difference spectrum were 
measured after 15 minutes. 
8.3 Results 
8.3a Inhibition of the side-chain cleavage reactions by 
arninoglutethimide phosphate 
To study the effect of aminoglutethimide on the side-chain 
cleaving system, 22R-OH cholesterol, 20a-OH cholesterol and 
~20-22 cholesterol were incubated both in presence and absence 
of the inhibitor. First the concentration of aminoglutethirnide 
phosphate needed for a complete inhibition of side-chain 
cleavage of cholesterol was estimated. 
Damaged bovine adrenal cortex mitochondria, supported by an 
NADPH-generating system, were used (fig. 8.1). 50% inhibition 
was obtained at a concentration of 30 ~MAGI, and no pregne-
nolone at all was produced at 120 ~M. In order to completely 
prevent pregnenolone production in the following experiments 
150 ~M AGI was used to inhibit cholesterol side-chain cleavage. 
22R-OH cholesterol 
The conversion of 22R-OH cholesterol by intact mitochondria in 
the presence of 150 ~M aminoglutethimide phosphate is shown 
in fig. 8.2. All 22R-OH cholesterol had been converted after 
8 minutes. However, only 75% of the expected amount of 
pregnenolone was formed. The conversion in the absence of AGI 
is shown in fig. 7.1. 
20~-0H cholesterol 
In the presence of 150 ~M AGI a marked decrease occurred in 
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Fig. 8.1 
Inhibition of cholesterol side-chain cleavage by amino-
glutethimide phosphate. 4 mg damaged mitochondria, containing 
45 nmol endogenous cholesterol/roW protein were incubated in 
2 ml medium (final volume) at 37 C. The medium contained: 
150 mM KCl, 11 roM NaCl, 50 roM nicotinamide, 20 roM Eepes 
(pH 7.30), 6 mM CaCl2, 4 mM sodium-azide, 1% bovine serum 
albumen, 4 ~g cyanoketone/mg mitochondrial protein, 2 ~g/ml 
antimycine. The reaction was started by the addition of 0.1 roM 
NADP+, 1.2 U glucose-6-phosphate dehydrogenase and 0.6 mM 
glucose-6-phosphate. After 15 min. in a shaking incubator the 
rearitions were terminated by shaking with 6 ml cold 
ethylacetate. 
the rate of conversion of 20a-OH cholesterol into pregnenolone 
(fig. 8.3), when compared with the experiment in the absence 
of AGI (fig. 7.2). Only 40% of the expected amount of pregne-
nolone was formed. Besides pregnenolone the same compound as 
described in chapter 7, (tentatively identified as 20a,25-di-
OH cholesterol) was formed. Complete conversion of all 20a-OH 
cholesterol took about 30 minutes. The total oxygen consumption 
76 
nmol STEROIDS 
so 
40 
30 
20 
10 
0 5 
------oo2 
10 
-·-·-·-·__. PREGNENOLONE 
15 
---···--·~ 200t,22A·Di·OH·CHOLESTEROl. 
o--------c 22A·OH·CHOLESTEAOL 
Fig. 8.2 
20 25 
80 
60 
40 
20 
0 
30MIN 
Conversion of 50 nmol (34 ~M) 22R-OH cholesterol into pregne-
nolone. The reaction conditions were similar as described in 
fig. 7.1 except for the presence of 150 ~M aminoglutethimide 
phosphate. 
after 30 minutes was 80% of what could be expected. 
~ 20 - 22 cholesterol 
In the presence as well as in the absence of 150 ~M AGI a 
marked increase in the oxygen uptake occurred after addition 
of succinate (fig. 8.4). The oxygen consumption of the 
respiratory chain was inhibited by antimycine and sodium azide. 
Addition of malate stimulated the side-chain cleavage of 
endogenous cholesterol and the associated oxygen uptake. AGI 
inhibited both malate stimulated cholesterol side-chain 
cleavage and oxygen uptake. The addition of the possible 
intermediate n20 - 22 cholesterol to the intact mitochondria 
resulted in an immediate oxygen uptake, which was not inhibited 
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Conversion of 20a-OH cholesterol into pregnenolone in the 
presence of 150 ~M aminoglutethimide phosphate. 20a,22R-di-OH 
cholesterol and 20a,25-di-OH cholesterol (tentatively 
identified) were formed during the reaction. Reaction 
conditions are similar as described for fig. 7.1. 
by 150 ~M aminoglutethimide phosphate. 
The small amount of available n20 - 22 cholesterol precluded 
the estimation of a stoichiometric relationship with respect 
to oxygen. 
8.3b The effect of AGI on the kinetics of side-chain cleavage 
The effect of AGI on the kinetics of the side-chain cleavage 
reactions was estimated by calculation of the V and the 
apparent Kro from the progress curves shown in fig. 7.1, 7.2, 
8.2 and 8.3. A least square curve-fitting method was used for 
HEPES PHOSPHATE 
BUFFER pH 7.3,37°C 
lMITO SUCC KINETICS OF 0 2 CONSUMPTION ~ ~AZIDE 
~AA 
~ MALATE ! ADDITION OF A20- 22 CHOLESTEROL 
'L 
0 2 4 6 MIN 
Fig. 8.4 
·······--..... L_l 
.•. 
',;-.., MALATE+ AMINOGLUTETHIMIOE 
"' , I ., ' : ..... ..... 
- ' ' : ' -..,: 
: ..... , ', 
~ ', ', 
- ' ' : ' ' 
PHOSPHATE 
~.. ', .......... 
.... ' ' 
.......... ', ........... 
.......... ',, 
.. 
.. 
.. 
.. 
.. 
.. 
.. 
.. 
"" .............. .. 
... 
........... 
The effect of the addition of ~ 20 - 22 cholesterol on the rate 
of oxygen consumption by intact bovine adrenal cortex 
mitochondria, both in presence and absence of 150 ~M amino-
glutethimide phosphate. For experimental conditions, see 
fig. 4.1. 
the integrated form of the Michaelis-Menten equation as des-
cribed (8.2c). The results of the calculations are shown in 
table 8. I. 
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Table 8.I 
The effect of AGI on the kinetics of the conversion of 20~-
0H cholesterol and 22R-OH cholesterol into pregnenolone. 
Substrate Km (~M) V(nmol/min"/ Ki(~M) 
mg prot.) 
22R-OH cholesterol 68 265 
id + 150 ~M AGI 73 185 347 
20a-OH cholesterol 24 94 
id + 150 ~M AGI 166 92 25 
V and the apparent Km were calculated from the progress curves 
shown in fig. 7.2, 7.3, 8.2 and 8.3. The Ki values were 
calculated using the value i = 150 ~M and the formulae: 
150 ~M AGI resulted in a slightly higher apparent Km value 
for the conversion of 22R-OH cholesterol and markedly decreased 
the V. The same AGI concentration produced a marked increase 
in the apparent Km of 20a-OH cholesterol. The V for this 
compound was not changed by the inhibitor. 
8.3c The effect of AGI on the rate of cytochrome P-450 
reduction 
The effect of AGI on the kinetics of the NADPH-supported 
cytochrome P-450 reduction is shown in table 8.II. 150 ~M 
inhibited the cholesterol side-chain cleavage reaction 
{fig. 7.3) and decreased the rate of reduction of cytochrome 
P-450 (table 8.II). Compounds producing a reverse type I 
absorbance spectrum with cytochrome P-450 (such as 22R-OH 
cholesterol, 20a-OH cholesterol and pregnenolone) decreased 
the rate of cytochrome P-450 reduction. 
Compounds giving a type I absorbance spectrum with 
cytochrome P-450 (25-0H cholesterol), increased the rate of 
cytochrome P-450 reduction. 
It is shown in table 8.II that adding 22R-OH cholesterol 
to mitochondria decreased the reduction rate to 73% of that 
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Table 8. II 
The effect of several sterols and steroids on the rate of 
cytochrome P-450.reduction in the presence and absence of 
aminoglutethimide phosphate. 
Blank 
Cholesterol (type I) 
20a-OH cholesterol 
(R I) 
22R-OH cholesterol 
(R I) 
Pregnenolone (R I) 
deoxycorticosterone 
(type I) 
25-0H cholesterol 
(type I) 
substr. 100 % blank x 
100 
98 
52 
73 
52 
97 
126 
16 
15 
42 
73 
12 
34 
37 
inhibition 
(%) pro-
duced by 
150 I!M AGI 
84 
85 
19 
0 
76 
65 
71 
Mitochondria (1.2 mg/ml) were incubated in the medium as des-
cribed in fig. 8.1. Cytochrome P-450 reduction rates were 
obtained by adding 75 ~M steroid (final concentration) to the 
medium. The initial rate found with the blank was 
4.2 ± 0.1 nmol cyt. P-450 reduced/min/mg protein. Type I: 
this compound induces a type I difference spectrum. R I yields 
a reverse type I difference spectrum. See also the appendix 
8.5. 
rate observed in the blank. Addition of AGI did not further 
decrease the reduction rate, it remained constant. AGI (in the 
absence of 22R-OH cholesterol) reduced the reduction rate to 
16%. Addition of 22R-OH cholesterol (a reverse type I sub-
strate) under these conditions increased the reduction rate 
from 16% to 73%. Apparently AGI had no effect on the rate of 
reduction in the presence of 22R-OH cholesterol. 
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8.3d Effect of AGI on the formation of a complex between 
cholesterol and cytochrome P-450scc 
At low pH (pH ; 6.40) cytochrome P-450scc and endogenous 
cholesterol form a complex (Mitani and Horie, 1969, Jefcoate 
and Boyd, 1971). From optical difference spectra and EPR-
spectra it can be concluded that this complex is in a high 
spin state. At high pH (pH ; 8.10) the heme iron atom of 
cytochrome P-450scc is converted into a low spin state. 
We confirmed the findings of Jefcoate and Boyd (1971), who 
showed that lowering the pH from 8.10 to 6.40 produced a 
complete reversal of the above spectral changes. This experi-
ment was repeated in the presence of 400 ~M AGI. The inhibitor 
induced a type II-amine difference spectrum with a minimum at 
390 nm and a maximum at 425 nm. The difference o~ the 
extinction at 390 nm and 410 nm, which is dependent on both 
the spin state and the concentration of cytochrome P-450scc 
(Jefcoate et al., 1973), was measured at different pH values. 
In fig. 8.5 it can be seen that in the presence of AGI the 
spin state could be changed from high to lovr spin and back to 
high spin under influence of the pH. Apparently, if cholesterol 
does form a complex with cytochrome P-450scc (high spin) under 
the influence of the pH changes, the presence of aminoglute-
thimide does not inhibit this interaction. 
8.4 Discussion 
8.4a Inhibition of the side-chain cleavage reaction 
The concentration of aminoglutethimide phosphate needed in 
our study for a virtually complete inhibition of cholesterol 
side-chain cleavage was 120 ~M. This is in reasonable agreement 
with the results of Cohen (1968) and Counsel et al. (1972). 
150 ~MAGI partially inhibit the conversion of 20a-OH 
cholesterol and 22R-OH cholesterol into pregnenolone and iso-
caproaldehyde. We have no quantitative data concerning the 
pregnenolone production from 6 20 - 22 cholesterol, but the oxygen 
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consumption, stimulated by the addition of this compound is 
not inhibited. 
f:l. (ABSORBANCE) 
[ 0.002 E 
6.6 7.0 
Fig. 8.5 
7.4 
--•• pH 6.4-pH 8.1 
pH 8.1-pH 6.4 
7.8 8.2 pH 
pH-induced changes in the spin state of cytochrome P-450scc· 
E390nm-E410nm was calculated from the difference spectrum 
obtained in the presence of aminoglutethimide phosphate 
(0. 4 mM). 
8.4b Effects of AGI on the kinetics of the side-chain cleavage 
reactions 
The side-chain cleavage of cholesterol is non-competitively 
inhibited by AGI (Bell and Harding, 1974). Our experiments 
show that the conversion of 22R-OH cholesterol into pregneno-
lone is also non-competitively inhibited by AGI. It has been 
suggested that AGI inhibits the cholesterol side-chain 
cleavage reaction by decreasing the rate of cytochrome P-450scc 
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reduction (Mcintosh and Salhanick, 1969). Our experiments 
(table 8.II) show that AGI inhibits the rat~ of cytochrome 
P-450 reduction in the presence of cholesterol by 85%. Using 
22R-OH cholesterol as a substrate, AGI does not at all in-
hibit the rate of cytochrome P-450 reduction (table 8.II). 
This somewhat unexpected result may be explained by the fact 
that by inhibiting the conversion of 22R-OH cholesterol into 
pregnenolone, AGI can exert its influence not only on the 
substrate but also on every intermediate of that reaction. In 
fact the reduction of cytochrome P-450scc is only a part of 
the whole process. The rate of reduction is estimated in the 
absence of oxygen and in the presence of carbonmonoxide. There-
fore no intermediates are formed by cytochrome P-450scc· 
Considering the experimental conditions, AGI may inhibit the 
conversion of 22R-OH cholesterol into pregnenolone non-
competitively (the V is decreased, the Km remains constant) 
but it does not necessarily have to inhibit the rate of 
cytochrome P-450scc reduction. Apparently, either the reduction 
of cytochrome P-450scc is not a rate-limiting process with 
22R-OH cholesterol as a subs.trite, or this sterol is not 
hydroxylated by cytochrome P-450scc at all. 
The side-chain cleavage of 20a-0H cholesterol is 
competitively inhibited by AGI (table 8.I). Although the 
maximum velocity (V) of that reaction is not decreased, the 
rate of cytochrome P-450 reduction is inhibited by 15%. 
Apparently the latter inhibition is not a rate-limiting 
process in the side-chain cleavage of 20a-OH cholesterol. A 
possible explanation may be given when the fact is considered 
that adrenal mitochondria contain at least three different 
cytochromes P-450: one for cholesterol side-chain cleavage, 
one for llS-hydroxylase and one for 18-hydroxylase. Each of 
these cytochromes P-450 contributes to the rate of cytochrome 
P-450 reduction measured by our method. A decrease in the rate 
of P-450 reduction does therefore not necessarily reflect a 
decrease in side-chain cleavage of 20a-OH cholesterol. 
In contrast to the side-chain cleavage of cholesterol, the 
side-chain cleavage of both 22R-OH cholesterol and 20~-0H 
cholesterol is not inhibited via a decrease in the rate of 
cytochrome P-450scc reduction. 
8.4c Inhibition of the enzyme-substrate formation between 
cholesterol and cytochrome P-450scc 
Recently Brownie and Paul (1974) and Paul et al. (1976) 
suggested an alternative mechanism of. inhibition by AGI, using 
intact adrenal cortex mitochondria from ACTH-treated rats. 
2 ~MAGI inhibited for about 50% the ACTH induced formation of 
an enzyme-substrate complex between cholesterol and cytochrome 
P-450scc· 
As the formation of a complex between cholesterol and 
P-450scc may also be induced by a change in pH, (Mitani and 
Horie, 1969; Jefcoate et al., 1971; Paul et al., 1976) we have 
investigated if AGI also inhibited the pH-induced formation of 
the cholesterol cytochrome P-450scc complex. 
low pH 
cholesterol + cyt. P-450scc (cholesterol cyt. 
high pH P-450scc complex) 
low spin high spin 
Fig. 8.5 shows that increasing the pH to 8.10 in the presence 
of 400 ~M AGI caused a dissociation of the cholesterol P-450scc 
complex. It can be converted into its original state by 
decreasing the pH to 6.40. 
From this experiment one may conclude that AGI does not 
inhibit the formation of a complex between cholesterol and 
cytochrome P-450scc· 
The results obtained in the experiments of Paul et al. 
(1976) differ from ours, but this may be explained by the 
different experimental conditions. Paul et al. (1976) used 
intact mitochondria from ACTH pretreated rats as the source of 
the cholesterol cytochrome P-450scc complex. In our experiments 
damaged bovine adrenal cortex mitochondria were used, while the 
enzyme-substrate complex was produced by a change in pH. 
8.4d The possible mechanisms of inhibition by AGI 
The available data are summarized in table 8.III. 
Table 8.III 
Author 
Boyd et al. 
(1975) 
Paul et al. 
(1976) 
This thesis 
Bell and 
Harding (1974) 
UZgiris et al. 
(1977) 
Falke et al. 
(1976) 
Falke (1977) 
AGI 
concen- System 
tration 
1 ~M intact rat adre-
nal mitochondria 
2 ~M intact rat adre-
nal mitochondria 
from ACTH pre-
treated animals 
30 ~M damaged bovine 
adrenal mito-
chondria 
25 llM damaged rat adre-
nal mitochondria 
26 ~M damaged corpus 
luteum mitochon-
dria 
Inhibi-
tion 
75% 
50% 
50% 
75% 
50% 
40 ].lM isolated rat adre- 50% 
nal cells, stirnu-
lated with ACTH 
Parameter 
Oz uptake 
heat generated 
type I absor-
bance change 
pregnenolone 
production 
pregnenolone 
production 
isocaproate 
production 
corticosterone 
production 
From the results in table 8.III we tend to conclude that forma-
tion of a complex between cholesterol and cytochrome P-450scc 
can be inhibited at low AGI concentrations if the structure 
of the mitochondria is intact. In damaged mitochondria there is 
a greater availability of the substrate cholesterol. This may 
explain why AGI is not able to inhibit the formation of the 
cholesterol cytochrome P-450scc complex. At higher AGI concen-
trations (25-30 ~M) side-chain cleavage of cholesterol is 
inhibited via a decrease in the rate of cytochrome P-450scc 
reduction. The high concentration of AGI (40 ~M) required for 
the inhibition of corticosterone production by intact rat 
adrenal cells may be exp~ained by a poor transport of the 
inhibitor through the adrenal cell membrane. 
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8. 5 F.ppendix 
25-0H cholesterol, 20CI.,22R-di-OH cholesterol and cholesterol 
produce so-called type I optical difference spectra 
(Arnax 385 nm, Amin 420 nro) upon interaction with adrenal 
cytochrome P-450 (Burstein et al., 1972). The type I optical 
difference spectrum is a reflection of the formation of an 
enzyme-substrate complex between cytochrome P-450 and the added 
steroid (Cheng and Harding, 1973). EPR spectra show that the 
type I optical difference spectrum corresponds with the 
transition of a low - to a high spin-state of the heme-Fe in 
cytochrome P-450 (Whysner et al., 1970). Compounds inducing 
type I spectra increase the rate of cytochrome P-450 reduction 
(Gigon et al., 1969). 
20a-OH cholesterol, 22R-OH cholesterol 
optical difference 
and pregnenolone 
spectra C\max 420 nm, produce reverse type I 
Amin 385 nrn) (Burstein et al., 1972) which are in fact mirror 
imaqes of the type I spectral chanqes. They are supposed to 
reflect the displacement of endogenously bound type I 
compounds (Diehl et al., 1970). Reverse type I, and type II 
optical difference spectra, are associated with a dissociation 
of the enzyme-substrate complex and a transition of a high to 
a low spin state of the heme-Fe. Reverse type I and type II 
compounds decrease the rate of reduction of cytochrome P-450scc 
(Gigon et al., 1969). 'I'he binding of aminoglutethimide to 
cytochrome P-450scc results in a type II difference spectrum 
(Mcintosh and Salhanick, 1969). EPR spectra show that this 
inhibitor changes the high spin complex for 100% into a lmV' 
spin amine complex (Jefcoate et al. 1973). The spin state of 
cytochrome P-450scc is also sensitive to pH changes (Mitani 
and Horie, 1969). Increasing the pH from 6.0 to 8.0 brings 
about a reversible change from a high to a low spin state of 
the heme-Fe (Jefcoate et al. 1973) . 
CHAPTER 9. 
DISCUSSION 
9.1 Current hypotheses about cholesterol side-chain cleavage 
At present {1977) three main hypothes~s exist for the con-
version of cholesterol into pregnenolone: 
1-a: cholesterol + 22R-OH cholesterol + 20a,22R-di-OH 
cholesterol + pregnenolone + isocaproaldehyde. 
1-b: cholesterol + 22R-OOH cholesterol + 22R-OH cholesterol 
+ 20a-OOH,22R-OH cholesterol + 20a,22'R-di-OH 
cholesterol + pregnenolone. 
1-c: cholesterol ->- 20a-OH cholesterol ->- 20a., 22R-di-OH 
cholesterol + pregnenolone. 
2 cholesterol ->- pregnenolone, via radical or ionic 
intermediates. 
3-a: cholesterol + 22R-OH cholesterol ->- b 2 o-zz cholesterol + 
20, 22-epoxy cholesterol + 20a, 22R-di-OH cholesterol ->-
pregnenolone. 
3-b: cholesterol + !::. 2 o- 2 2 cholesterol ->- etc. 
The mechanism with consecutive hydroxylations (hypothesis 
1-a) is defended by Burstein et al. (1974, 1975, 1976a,b) 
and van Lier et al. (1977; hypothesis 1-b) _ According to these 
authors 22R-OH cholesterol, and not 20a-OH cholesterol is the 
main intermediate sterol. 
Morisaki et al. (1976) detected 20~-0H cholesterol during 
the conversion of cholesterol to pregnenolone and they claim 
that a significant percentage of cholesterol is transformed 
into pregnenolone via 20a-OH cholesterol (hypothesis 1-c). 
The involvement of radical or ionic intermediates (hypo-
thesis 2) has been proposed by Luttrell et al. (1972), Hochberg 
et al. (1974, 1976a,b). 
A side-chain cleaving mechanism involving !::. 20 - 22 cholesterol 
and 20,22-epoxy cholesterol (hypotheses 3-a, 3-b) has been 
suggested in chapter 4, 5 and 6 (Kraaipoel et al. 1974a, 
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1974b, 1975a, band c). The involvement of 22R-OH cholesterol 
(hypothesis 3-b} has been discussed in chapter 6. 
9.2 The classical scheme and the epoxy-dial hypothesis. 
The main difference between the hypotheses supported by 
Burstein et al. (1974, 1975, 1976a, b), van Lier et al. (1977), 
Morisaki et al. (1976) and us, can be found in the conversion 
of 22R-OH cholesterol into 20~,22R-di-hydroxycholesterol. 
According to Burstein, 22R-OH cholesterol is hydroxylated to 
20~,22R-di-OH cholesterol via a mixed-function oxygenase. 
This reaction is catalyzed by cytochrome P-450scc and requires 
NADPH and 0 2 • In contrast to this proposal, we suggest 
(chapter 5} that 22R-OH cholesterol is first converted into 
~ 20 - 22 cholesterol by a dehydratase. ~ 20 - 22 cholesterol is 
then converted into 20,22-epoxy cholesterol by an epoxydase, 
probably a mixed-function oxygenase requiring NADPH and Oz. 
The epoxy-cholesterol is then converted into 20~,22R-di-OH 
cholesterol by an epoxyhydrase. The enzyme incorporates a 
molecule of water to give a dihydroxy-compound. The results 
of our experiments (chapter 6) sug<;rest that t1..ro dihydroxyl-
~roups of 20~,22R-di-OH cholesterol are formed with oxygen 
atoms from molecular oxygen (0 2 ) and water (H 2 0}. The oxygen 
atom attached to Czo from the glycol originates from molecular 
oxygen, the oxygen atom attached to Czz originates from 
water. 
The hypothesis advocated by Burstein is supported by a 
number of experiments. Burstein et al. (1974) have reported 
that incubation of cholesterol with an acetone powder of 
bovine adrenal cortex mitochondria, in the presence of 18 0 2 , 
resulted in the formation of 20a,22R-di-OH cholesterol. Both 
hydroxyl-groups contained 18 0. Burstein therefore concluded 
that both hydroxyl-groups were formed with two separate 
molecules of oxygen ( 18 0 2 ) and that two hydroxylation reactions, 
requiring molecular oxygen were involved in the synthesis of 
20a,22R-di-OH cholesterol. 
This experiment can however also be explained by the epoxide-
diol hypothesis. NADPH and Oz, both required for the side-chain 
cleavage reactionF are converted into NADP+ and H20 during 
the reaction. Evidently with 18 0 2 , 18-oxygen labeled water is 
formed. In an acetone powder and in purified cytochrome 
P-450scc (supported by flavoprotein and adrenodoxin) part of 
the NADPH oxidation is not coupled to the side-chain cleavage 
reaction (Shikita and Hall, 1974). In the presence of 18 0 2 , 
this NADPH-oxidase produces H2 180. Therefore synthesis of the 
glycol via an epoxide-diol pathway, in the presence of 180 2 
and H2 180, will result in the formation of 20a,22R-di-OH 
cholesterol with 180 on both C20 and Czz. 
The same experiments (Burstein et al. 1974) give further 
support for our explanation. The cholesterol side-chain 
cleavage reaction was supported by NADPH, generated by 
glucose-6-phosphate, glucose-6-phosphate dehydrogenase and 
NADP+. Two experiments were performed, with different concen-
trations glucose-6-phosphate dehydrogenase. With the lower 
enzyme concentration an 18 0 abundance in both hydroxyl-groups 
of 60% was found. A twofold increase of the concentration 
glucose-6-phosphate dehydrogenase resulted in a 90% 180 abun-
dance in the same hydroxyl-groups. 
It is likely that by increasing the glucose-6-phosphate de-
hydrogenase concentration, a higher concentration of NADPH 
is obtained. Therefore the rate of Hz 18 0 formation from 
NADPH-oxidases not coupled to the side-chain cleavage reaction 
will be higher. The increased availability of H2 180, for the 
epoxyhydrase will result in an increased incorporation into 
the glycol. In this way the increased 18 0-content {90%) may 
be explained. 
More recently Burstein and Gut (1976b) reported an experi-
ment that can be explained in a similar way. Cholesterol and 
an acetone powder prepared from adrenal cortex mitochondria 
were incubated in a 180 2 enriched atmosphere. When the gas 
phase·was abruptly changed to air ( 160z) and the incubation 
continued for a relatively short period, a drop occurred in 
the 180-content of 22R-OH cholesterol and 20a,22.R-di-OH 
cholesterol. The 18 0-content of 20a,22R-di-OH cholesterol was 
lower at position C2 o than at Czz. Burstein and Gut explained 
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this finding by assuming that cholesterol is first hydroxy-
lated at C22 and than at C20 . Upon changing the gasphase 
abruptly from 18 02 to 16 02, the 22R- 18 0H cholesterol present 
in the incubation mixture will be converted into 20~- 16 0H,22R-
180H cholesterol. 
An alternative explanation can be given based upon the epoxide-
diol hypothesis. In the presence of 18 0 2 , the enzyme prepara-
tion catalyzes the reduction of 180 2 by NADPH to NADP+ and 
H2 18 0. Upon changing the 180 2 atmosphere for air, H2 16 0 will 
be formed but some H218 0 will still be present within the 
enzyme preparation. 20,22-epoxy cholesterol formed, will 
contain 16 0 from molecular oxygen ( 16 0 2). The epoxyhydrase 
converts epoxy cholesterol and H2 180 into 20~,22R-di-OH 
cholesterol with 180 at C22 . The oxygen atom originating from 
molecular oxygen is then attached to C20 . According to our 
explanation an abrupt change in the gasphase will also result 
in a lower 180-content at C2o than at C22· 
In the literature a few experiments are reported that can 
not easily be explained by the epoxide-diol hypothesis~ but 
there are also experiments that can not be explained by a 
mechanism consisting of consecutive hydroxylation. Burstein et 
al. (1976a) reported the synthesis of 22R- 180H cholesterol. 
Incubation of this 18 0 labeled substrate with an acetone powder 
of bovine adrenal cortex mitochondria resulted in the formation 
of 20a,22R-di-OH cholesterol with the same 18 0 abundance in the 
hydroxyl-group at C22 as the starting material. The hydroxyl-
group at C2o did not contain 180 and as expected, no 180 was 
found in the pregnenolone formed. This retention of the 18 0 
label at C22 does not fit within the epoxide-diol hypothesis. 
In the same paper the incubation of the two stereo-isomers 
of ~ 20 - 22 cholesterol (E and Z) is reported. Both isomers did 
not yield significant amounts of 20~,22R-di-OH cholesterol or 
pregnenolone. A similar result has been reported by Morisaki 
et al. (1976a) who incubated one of the stereo-isomers of 
6 20 - 22 cholesterol, {E)-20(22)-dehydrocholesterol. These 
results are in contrast to the conversion of ~ 20 - 22 cholesterol 
as reported in chapter 4. 
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The following comments can be made, however: 
1. The synthesis of E and Z fi 20 - 22 cholesterol by Burstein 
et al. (1976a) was performed under rather drastic condi-
tions and the purity of the material used was not 
established. 
2. Models of both stereo-isomers give the impression that 
only (Z)-20(22)-dehydrocholesterol may interact with the 
active site of the enzyme system. 
Both Burstein et al. (1976a) and Morisaki et al. (1976a) 
synthesized the four stereo-isomers of 20,22-epoxy cholesterol. 
Only (20R,22S)-20,22-epoxy cholesterol formed pregnenolone in 
approximately 20% of the yield obtained with cholesterol 
(Burstein et a1. l974a). The same substrate produced the 
highest inhibition (30%) of side-chain cleavage of 1 ~C-choles­
terol (Morisaki et al. 1976a). In contrast to the results of 
Burstein the Japanese group did however, not find a significant 
conversion of (20R,22S)-20,22-epoxy cholesterol to pregnenolone. 
According to Burstein et al. (1976b), the slight transformation 
of the epoxide to pregnenolone suggests that an epoxide hydrase 
may exist in their acetone-dried powder preparation although 
this was not proven. 
According to Oesch (1972) liver epoxyhydrase has a very 
low affinity for its substrates. An inhibitor of several 
epoxyhydrases, 1,1,1-trichloropropene-2,3-oxide (TCPO), has 
been described (Oesch et al. 1971); 0.4 rnM TCPO almost 
completely inhibited epoxyhydrase from human liver microsomal 
fractions (Oesch 1974). A slow penetration of this inhibitor 
was described by Croteau and Kopattukudy (1974), who pre-
incubated one hour with 10 rnM TCPO and obtained a 50% inhibi-
tion of a plant epoxyhydrase. In addition Oesch (1971) 
reported that the formation of a dihydrodiol from exogenous 
naphtalene oxide was effectively inhibited by TCPO, while the 
conversion of naphtalene oxide endogenously formed from 
naphtalene was not inhibited. In our experience the inhibitor 
requires one hour preincubation at room temperature with 
damaged bovine adrenal cortex mitochondria to obtain a marked 
inhibition of the epoxyhydrase activity without affecting the 
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cytochrome P-450scc catalyzed reactions. 
Considering the low affinity of epoxyhydrase for their 
substrates and the slow penetration of the inhibitor TCPO, 
one may not expect a very efficient conversion of exogenous 
20,22-epoxy cholesterol to 20a,22R-di-OH cholesterol. Moreover 
the availability of the added 20,22-epoxy cholesterol to the 
active site of the enzyme epoxyhydrase, may be lower than the 
availability of 20,22-epoxy cholesterol endogenously formed 
from cholesterol. These considerations may well explain the 
low yield of pregnenolone obtained from the incubation with 
(20R,22S}-20,22-epoxy cholesterol. 
9.3 Cholesterol side-chain cleavage via ionic or radical 
intermediates. 
A mechanism of cholesterol side-chain cleavage, involving 
radical or ionic intermediates, has been proposed by Lieberman 
et al. (1969}, and Luttrell et al. (1972}. By using an analog 
of 20a-OH cholesterol, with a tertiary C22, a possible fission 
of the C20 -C 22 bond could not occur via a stable 20-22 glycol. 
The authors found that incubation of (20R}-20-t-butyl-5-
pregnene-3S,20-diol, with an acetone powder of bovine adrenal 
cortex mitochondria resulted in a pregnenolone production of 
0.5 to 1.2%. 
This artificial substrate is, however, difficult to synthe-
size in a 100% pure form. Re-arrangement of the t-butyllithium 
used in the synthesis might occur under formation of isobutyl-
lithium and a compound with a secondary C2 2 will then be formed. 
Separation of these two products will be very difficult, if 
not impossible. The low conversion of the analog of 20a-OH 
cholesterol into pregnenolone may therefore be explained by 
side-chain cleavage of the impurity. Since the latter product 
has one free H-atom at C2 2, the results fit both the hypo-
theses of the classical and the epoxide-diol pathways. 
To circumvent these problems, a 20-p-tolyl analog of 20a-
OH cholesterol was synthesized (Hochberg et al. 1974}. This 
substrate was converted into pregnenolone and progesterone 
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with a good efficiency (23%). The 20-p-tolyl analog of choles-
terol was converted into its 20a-hydroxy derivative in a 
yield of 21%, suggesting the existence of a 20a-hydroxylase 
system in the acetone powder of bovine adrenal cortex mito-
chondria. However, the cleavage of these two substrates can 
also easily be explained by the formation of a double bond 
between C2o and Czz, followed by the formation of a C2o-22-
epoxide, which is further converted into a C2 o-z2 glycol, 
analogous to 20a,22R-di-OH cholesterol. 
The styrene 20-(p-tolyl)-5,20-pregnadien-38-ol can not 
rearrange to a compound with a double bond between C2o and 
Czz. It can therefore not be cleaved via the epoxide-diol 
pathway. Interestingly, Hochberg et al. (1974) report that 
this styrene is not a substrate for the cholesterol side-chain 
cleaving system. 
To preclude a possible rearrangement to a Czo-Cz~ double 
bond, Hochberg et al. (1976a) next synthesized the 20-phenyl-
analog of 20a-OH cholesterol, (20R)-20-phenyl-5-pregnene-38, 
20-diol. This compound was cleaved by an acetone powder of 
bovine adrenal cortex mitochondria to form pregnenolone and 
phenol in a yield of 5%. Furthermore a C19-fragment {17-methyl-
18-norandrosta-5,13{17)-dien-3S-ol) and a C8 -ketone, n-methyl-
2-heptanone were found in a yield of 0.5%, suggesting a 
cleavage of the c 1 ,-C 20 bond. (Hochberg et al. 1976b). 
The 20-phenyl analog of 20a-OH cholesterol can not easily 
rearrange to an isomer with a Czo-z 2 double bond, but the 
involvement of transient radical or ionic intermediates is 
not a prerequisite if oxygen insertion between Czo and C22 
{Constantopoulos et al. 1962} or between C17 and C20 {Trager 
p. 54) is taken into consideration. 
Cleavage of the C17-C 20 bond of the 20-phenyl analog might 
be initiated by splitting off H20 ·.vhich results in the forma-
tion of a C1 7-C 2 o double bond. After epoxidation the C1 7_ 20 -
epoxide might rearrange to a four-membered ring 18,20 oxide 
with migration of the C1 8 -methyl group to C1 7, as pointed out 
by Wendler, (1964). 
It is interesting to note that on basis of the results of 
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the cleavage of the C11-2o bond of the phenyl analog, 
Hochberg et al. (l976b) incubated 20a-OH cholesterol with an 
acetone powder prepared from mitochondria obtained from the 
cortex of bovine adrenals. No Cs-ketone (6-methyl-2-heptanone) 
was formed. Neither did the incubation of 17a,20a-dihydroxy-
cholesterol with a guinea pig adrenal preparation result in 
cleavage of the C1 7 _ 20 bond (Burstein et al. 1968). 
The existence of radical or ionic intermediates in the 
mechanism of cholesterol side-chain cleavage is compatible 
with the experiments of Hochberg et al. (1976a, b). Other 
explanations are possible, however, and it remains to be 
proven that the hydroxylated sterols 22R-OH cholesterol and 
20a,22R-di-OH cholesterol, isolated during cholesterol side-
chain cleavage, are merely by-products, resulting from as yet 
undefined reversible transformations of the true intermediates. 
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9.4 The congenital lipoid adrenal hyperplasia (CLAH) and the 
epoxide-diol hypothesis. 
In CLAH (Prader and Siebenrnann, 1957) large quantities of 
cholesterol and cholesterol-esters accumulate in the adrenals 
and almost no steroids are formed. Apparently cholesterol is 
not converted into pregnenolone. CLAH can be expected to have 
two main causes. 
I. A defect in the transport of adrenal cholesterol to the 
active site of cytochrome P-450scc· 
At present not enough is known about the exact transport 
mechanisms to enumerate the possible defects. 
II. Defects in the cholesterol side-chain cleavage proper. 
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The enzyme system, capable of pregnenolone formation 
from cholesterol, has, according to the epoxide-diol 
hypothesis, several activities. 
In principle, each of these could be affected. 
A1 cholesterol+ ~ 20 - 22 cholesterol. 
The conversion occurs via an oxidative desaturase, 
requiring NADPH and oxygen. 
NADPH + flavoprotein (a) + non-heme iron protein (b) + 
desaturasejcytochrome P-450 (c). 
A2 cholesterol + 22R-OH cholesterol -)- IJ. 2 0 - 22 cholesterol. 
The conversion occurs via 22R-hydroxylation followed 
by a dehydratase. 
NADPH + Fp (a) + NHI (b) + cyt. P-450 (d) + dehydratase 
(e) • 
B. A20 - 22 cholesterol+ 20,22-epoxycholesterol. 
The reaction is catalyzed by an epoxydase, NADPH and Oz 
are required. 
NADPH + Fp (a)+ NHI (b)+ cyt. P-450 (f). 
C. 20,22-epoxycholesterol + 20a,22R-di-OH cholesterol. 
The reaction is catalyzed by an epoxyhydrase (g) and 
requires H20. 
D. 20a,22R-di-OH cholesterol -)- pregnenolone + isocaproal-
dehyde. 
The reaction is catalyzed by a lyase. NADPH and 02 are 
required. 
NADPH + Fp (a) + NHI (b)+ cyt. P-450 (h). 
Damaged mitochondria or acetone powders, prepared from 
adrenals with defect(s) I, can be expected to have the capa-
bility of pregnenolone formation from cholesterol. 
The sites of possible type II defects are A, B, C and D. 
Sequential testing of cholesterol and the intermediates in the 
side-chain cleavage reaction with a mitochondrial preparation 
should allow to distinguish between these defects in a case 
of CLAH. 
Further differentiation (a, b, c, d, e, f, g and h) is theo-
retically possible, but technical difficulties are at present 
the limiting factors. The components (a and b) of the electron 
transport chains are, for lack of evidence, supposed to be 
non-specific. Furthermore it is not known whether the cyto-
chromes c, d, f and h are different chemical entities. The 
possibility exists that only one kind of cytochrome P-450 
catalyzes the whole cholesterol side-chain cleavage. In this 
case c, d, f and h are identical. 
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SUMMARY 
The cleavage of the side-chain of cholesterol is one of the 
most important enzymatic reactions in adrenal steroidogenesis~ 
The products are pregnenolone and isocaproaldehyde. The 
pregnenolone formed is the starting point in the biosynthesis 
of the adrenal steroids. 
This thesis describes the results of an investigation of 
the enzyme system catalyzing this cleavage reaction. The 
results obtained can be used in studies concerning an almost 
always lethal disease, congenital lipoid adrenal hyperplasia. 
In this condition the cholesterol side-chain cleaving system 
is effected, resulting in a very low activity. 
The aims of the investigation are given in chapter 1. The 
methods used are briefly described. After a discussion of the 
Cahn-Ingold-Prelog nomenclature it is explained why, in this 
thesis, the old nomenclature is used. 
In chapter 2 an historical survey is given of the work 
leading to the generally accepted hypothesis of the mechanism 
of pregnenolone formation from cholesterol. A statement of the 
problem is. __ given, based on the knowledge available in 1971. 
The reasons for the use of gaschromatographic estimation of 
the various sterols and steroids are given in chapter 3. The 
combination of gaschromatography and mass spectrometry provided 
us with the possibility to study the mechanism of the enzyme 
system by means of 18 0 incorporation into intermediate and 
end-products. 
In chapter 4 experiments are described concerning the 
enzymatic conversion of 20a-OH cholesterol into pregnenolone. 
The reactions were performed in the presence of the non-radio-
active H2 18 0. The pregnenolone formed was found to contain 18 0. 
The incorporation of a molecule of water, occurring during the 
biosynthesis of pregnenolone, cannot be explained by the 
existing hypotheses. To explain the results of the experiments, 
described in chapter 4, a new hypothesis is presented {see 
figure A). During the enzymatic conversion of 22R-OH 
cholesterol into pregnenolone and isocaproaldehyde (chapter 5) 
an intermediate is formed, identified as 20a,22R-di-OH 
cholesterol. During the reaction the sum: 
(substrate) + (intermediate) + (end-product) appeared to be 
smaller than the initial substrate concentration. Apparently 
(an) intermediate(s), which could not be measured, was/were 
present. In the presence of > 99% carbon monoxide this/these 
unknown intermediate(s) appeared to be converted into the 
intermediate 20a,22R-di-OH cholesterol. The sum of the amounts 
of substrate, intermediate and end-product was then 
approximately equal to the initial amount of substra·te. It is 
concluded that, besides the CO-inhibited cytochrome P-450scc, 
an enzyme is present, which is capable of converting the 
unknown intermediate(s) into 20a,22R-di-OH cholesterol. This 
experiment supports our hypothesis, that an epoxyhydrase is 
involved in the biosynthesis of pregnenolone. An epoxyhydrase 
could convert 20~,22~-epoxy cholesterol in the presence of 
water. None of the epoxyhydrases described in the literature, 
are inhibited by CO, where this has been studied. 
The conversion of cholesterol into pregnenolone and iso-
caproaldehyde in the presence of H2 18 0 is described in chapter 
6. The mass spectrometric analyses of the intermediate 20a,22R-
di-OH cholesterol proved that 18 0 was attached to C-22 only. 
A similar result was obtained with 22R-OH cholesterol (chapter 
4) • 
The estimation of the number of molecules of oxygen, 
required for the reaction: 
1 22R-OH cholesterol + 1 pregnenolone + 1 isocaproaldehyde 
is described in chapter 7. The reaction required 2 molecules 
of oxygen. This result is in agreement with the accepted 
hypothesis of cholesterol side-chain cleavage, and with the 
epoxide-diol hypothesis, proposed in this thesis. 
The effects of the inhibitor, aminoglutethimide phosphate, 
(abbreviated AGI, "commercial name" Elipten) on cholesterol 
side-chain cleavage are described in chapter 8. AGI inhibits 
the conversion of cholesterol into pregnenolone. It was 
examined whether the side-chain cleavage of the substrates 
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20a-OH cholesterol and 22R-OH cholesterol were inhibited via 
the same mechanism as found for cholesterol, i.e. by a 
decrease in the reduction rate of cytochrome P-450scc· This is 
most probably not the case. The validity of another recent 
proposal was examined. It has been postulated that AGI in-
hibited the formation of an enzyme substrate complex at a site 
between cholesterol and cytochrome P-450scc· Our findings 
combined with data from the literature allowed us to conclude 
that the formation of a complex can only be inhibited if the 
adrenal mitochondria, containing the cytochrome P-450scc' are 
intact. In damaged mitochondria, cholesterol seems to be 
readily available for cytochrome P-450sccr preventing 
inhibition by AGI. 
The most important current hypotheses are discussed in 
chapter 9. In contrast to the earlier described hypotheses, 
the mechanism suggested in this thesis allows explanation of 
both the incorporation of a molecule of water (H 2 18o) and the 
lack of inhibition of the 20a,22R-di-OH cholesterol formation 
by carbon monoxide. The epoxide-diol hypothesis is also in 
accordance with the results of almost all pertinent experi-
ments described in the literature. Based upon the epoxide-
diol hypothesis the different enzyme defects able to cause 
congenital lipoid adrenal hyperplasia are discussed. 
Using tissues obtained post mortem, it is possible to localize 
these enzymedefects. 
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Fig. A 
The scheme for conversion of cholesterol and pregnenolone, as 
proposed in this thesis. The most likely point of inhibition 
in this scheme is indicated. 
There are 2 pathways to 6 40 - 22 cholesterol possible in this 
scheme, shown here by dotted arrows. 
20a-OH cholesterol is shown in a box to emphasize that this 
substrate is not a intermediate in the side-chain cleaving 
system. 
CO: carbon monoxide. The point of inhibition is indicated. 
TCPO: 1,1,1-trichloro-propene-2,3-oxide, an epoxyhydrase 
inhibitor. 
Hz 18 o: The labeled oxygen atom is bound only to the C-22 atom 
of 2Da,22R-di-OH cholesterol. 
Oz: The scheme indicates that the conversion of molecule of 
cholesterol into 1 molecule of pregnenolone and molecule of 
isocaproaldehyde requires 3 molecules of oxygen. 
For the conversion into the same products, 20a-OH cholesterol, 
6 2 o-zz cholesterol and 22R-OH cholesterol each require 2 
molecules of oxygen. 
20,22-epoxycholesterol and 20a,22R-di-OH cholesterol each 
require 1 molecule of oxygen. 
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SAMENVATTING 
Als een van de eerste stappen in de steroidsynthese van de 
bijnieren wordt de zijketen van cholesterol afgesplitst, waar-
bij pregnenolon en isocaproaldehyde ontstaan. In dit proef-
schrift zijn de resultaten beschreven van een onderzoek over 
het enzym-systeem dat deze reaktie katalyseert. Het gevormde 
pregnenolon dient als ui tgangspunt voor de steroidsynt.hese van 
de bijnieren. De via dit onderzoek verkregen kennis zou van 
toepassing kunnen zijn bij het zoeken naar de oorzaak (oorza-
ken) van een bijna altijd dodelijke aandoening, de congenitale 
bijnier lipoidhyperplasie. Bij deze aandoening is de werking 
van het zijketensplitsende enzym-systeem, dat cholesterol in 
pregnenolon en isocaproaldehyde omzet, gestoord. 
In hoofdstuk 1 wordt het doel van het onderzoek weergegeven. 
In het kort is beschreven welke methoden zijn gebruikt. Na een 
beknopte behandeling van de Cahn-Ingold-Prelog nomenclatuur 
wordt uiteengezet waarom in dit proefschrift is gekozen veer 
de oude nomenclatuur. 
In hoofdstuk 2 wordt een historisch overzicht gegeven van 
het we~k dat geleid heeft tot de algemeen geaccepteerde 
hypothese over het mechanisme van de pregnenolon-vorming uit 
cholesterol. Uitgaande van de in 1971 beschikbare kennis van 
het betrokken enzym-systeem wordt vervolgens de probleem-
stelling geformuleerd. 
De redenen veer het gebruik van een gaschromatografische 
bepaling van de verschillende sterolen en steroiden worden in 
hoofdstuk 3 gegeven. De kombinatie van gaschromatografie en 
massa-spectrometrie maakte het mogelijk om via de inbouw van 
18 0 in tussen- en eindprodukten, de werking van het enzym-
systeem te bestuderen. 
In hoofdstuk 4 zijn de experimenten beschreven over de 
enzyrnatische omze:tting, van 20a.-OH cholesterol in pregnenolon. 
De reakties werde~ uitgevoerd in aanwezigheid van (het niet-
radioaktieve) H2 18 o. Het gevormde pregnenolon bleek 18 0 te be-
vatten. De inbouw van een molekuul water, zeals hier beschreven 
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voor de biosynthese van pregnenolon, is echter in strijd met 
de gangbare hypotheses. Om de resultaten van de in hoofdstuk 
4 beschreven exper~enten te kunnen verklaren wordt een 
nieuwe (epoxide-diol) hypothese voorgesteld (zie figuur A). 
Bij de enzymatische omzetting van 22R-DH cholesterol in 
pregnenolon en isocaproaldehyde (hoofdstuk 5) werd een tussen-
produkt gevor.md, dat met behulp van massa-spectrometrie als 
20~,22R-di-OH cholesterol geidentificeerd ken worden. Gedurende 
de reaktie bleek de scm van het aantal nmol substraat, tussen-
produkt en eindprodukt kleiner te zijn dan het aantal nmol 
substraat waar.mee de reaktie was gestart. Blijkbaar waren er 
tussenprodukten aanwezig die niet gemeten werden. Deze onbe-
kende tussenprodukten bleken in aanwezigheid van > 99% keel-
monoxide in het (geidentificeerde) tussenprodukt 20~,22R-di-OH 
cholesterol omgezet te worden. De scm van de hoeveelheden sub-
straat, tussenprodukt en eindprodukt was dan bijna gelijk aan 
de hoeveelheid substraat waarmee de reaktie gestart werd. Hier-
uit is gekonkludeerd dat naast het cytochroom P-450scc• dat 
door koolmonoxide wordt geremd, een enzym werkzaam is, dat in 
staat is om een onbekend tussenprodukt in 20a,22R-di-OH 
cholesterol om te zetten. Dit experiment ondersteunt onze ver-
onderstelling dat een epoxyhydrase betrokken is bij de bio-
synthese van pregnenolon. Een epoxyhydrase zou een 20,22-
epoxycholesterol in aanwezigheid van water (H,O) in 20~,22R­
di-OH cholesterol kunnen omzetten, terwijl ook bekend is dat 
de werking van de in de literatuur beschreven epoxyhydrases 
niet door koolmonoxide wordt geremd. 
In hoofdstuk 6 is de omzetting van cholesterol in pregne-
nolon en isocaproaldehyde in de aanwezigheid van H2 1 e0 beschre-
ven. Uit de massa-spectrometrische analyse van het tussenpro-
dukt bleek dat het 180 uitsluitend aan het C-22 atoom van het 
tussenprodukt 20~,22R-di-OH cholesterol gebonden was. Eenzelfde 
resultaat werd bereikt bij een onder vergelijkbare omstandig-
heden uitgevoerde inkubatie van 22R-OH cholesterol (hoofd-
stuk 4). 
De bepaling van het aantal molekulen zuurstof dat nodig is 
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voor de reaktie: 
1 22R-OH cholesterol + 1 pregnenolon + 1 isocaproaldehyde 
wordt in hoofdstuk 7 beschreven. Er bleken 2 molekulen zuur-
stof nodig te zijn om de reaktie te laten verlopen. Dit is in 
overeenstemming met zowel de in de literatuur meest gangbare 
hypothese omtrent de cholesterol zijketensplitsing, als met de 
door ons voorgestelde epoxide-diol hypothese. 
In hoofdstuk 8 worden de effekten van de remmer aminoglu-
tethimide fosfaat (afgekort AGI, merknaarn Elipten) op de door 
cytochroom P-450scc gekatalyseerde zijketensplitsing beschre-
ven. AGI remt de omzetting van cholesterol in pregnenolon. 
Nagegaan werd of de substraten van het bestudeerde enzym-
systeem, 20n-OH cholesterol en 22R-OH cholesterol, op analoge 
wijze als cholesterol, d.w.z. door vertraging van de snelheid 
van de reduktie van het cytochroom P-450sccr werden geremd. 
Dit bleek niet het geval te zijn. Tevens werd de juistheid van 
een recente veronderstelling onderzocht, waarbij werd gepostu-
leerd dat AGI de vorming van een enzyms.ubstraat komplex tussen 
cholesterol en cytochroom P-450scc verhindert. Mede op grond 
van literatuur gegevens werd gekonkludeerd dat remming van de 
komplex-vorrning door AGI alleen mogelijk is indien de bijnier-
mitochondrien, die het cytochroom P-450 5 cc bevatten, intakt 
zijn. In niet-intakte mitochondrien is waarschijnlijk de be-
schikbaarheid van het cholesterol voor cytochroom P-450 5 cc zo 
groat, dat AGI niet effektief kan remmen. 
In hoofdstuk 9 worden de belangrijkste hypotheses van dit 
ogenblik besproken. In tegenstelling tot eerder beschreven 
hypotheses kan met het door ens voorgestelde mechanisme zowel 
de inbouw van een molekuul water (H2 18 0) als de niet door CO 
geremde vorming van 20a,22R-di-OH cholesterol verklaard worden. 
De e.poxide-diol hypothese is toepasbaar bij de verklaring van 
de resultaten van bijna alle in de literatuur beschreven ex-
perimenten. Aan de hand van de epoxide-diol hypothese worde~ 
de verschillende enzymdefecten besproken die oorzaken van 
congenitale bijnier lipoid hyperplasie kunnen zijn. Het is 
mogelijk met geschikt autopsie materiaal de enzyrndefecten te 
localiseren. 
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Fig. A 
Het schema voor de omzetting van cholesterol in pregnenolon 
en isocaproaldehyde, zeals voorgesteld in dit proefschrift 
wordt in dit figuur weergegeven. 
AGI: a~inoglutethimide fosfaat. In dit schema is het meest 
waarschijnlijke aangrijpingspunt van deze remmer aangegeven. 
De gestippelde pijlen geven aan dat dit schema de keuze 
tussen de twee mogelijke wegen naar ~ 20 - 22 cholesterol open 
laat. 20~-0H cholesterol is in een kader geplaatst om uit te 
laten komen dat dit substraat geen tussenprodukt is van het 
zijketen splitsende enzym-systeem. 
CO: koolmonoxide. Het aangrijpingspunt van deze remmer is 
aangegeven. 
TCPO: 1,1,1-trichloro-propene-2,3-oxide, een epoxyhydrase 
remmer. 
H2 18 o: Het gelabelde zuursto£ atoom wordt slechts gebonden 
aan het C-22 atoom van 20a,22R-di-OH cholesterol terug 
gevonden. 
02: Uit het schema blijkt ~at voor de omzetting van 1 molekuul 
cholesterol in 1 molekuul pregnenolon en 1 molekuul isocapro-
aldehyde 3 molekulen zuurstof nodig zijn. 
Voor de omzetting in Aezelfde produkten gebruiken 20a-OH 
cholesterol, 6~ 0 - 22 cholesterol en 22R-OH cholesterol elk 2 
molekulen zuurstof. 
20~22-epoxycholesterol en 20a,22R-di-OH cholesterol gebruiken 
volgens het schema elk 1 molekuul zuurstof. 
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CURRICULUM VITAE 
(op verzoek van de faculteit). 
De schrijver van dit proefschrift behaalde in 1962 het 
diploma H.B.S.-B aan het Spinoza Lyceum te Amsterdam. 
In hetzelfde j aar liet ~1ij zich inschrijven als student 
scheikunde aan de Universiteit van Amsterdam. Samen met 
A.H.J. van der Stap behaalde hij in 1965 het nederlands 
kampioenschap roeien in het nuromer dubbel-twee. Het 
candidaatsexamen \'lerd afgelegd in 1968 en het doctoraal-
examen scheikunde in 1971 (hoofdvak biochemie, bijvak 
fysiologie en keuze richting radiochemie) . Na het doctoraal-
examen was hij als wetenschappelijk medewerker 'iverkzaam op 
de afdeling kindergeneeskunde van de Erasmus Universiteit 
te Rotterdam, ah;aar het in dit proefschrift beschreven 
onderzoek werd verricht. Gedurende het cursusjaar 1971/72 
gaf hij enkele uren per \Veek scheikunde-les aan de eind-
examenklas van een MAVO. In december 1975 1.verd de schrijver 
van dit proefschrift aangesteld als hoofd van het klinisch-
chemisch laboratorium van het Oogziekenhuis te Rotterdam. 
In december 1976 volgde een aanstelling als 'irletenschappelijk 
medewerker op de afdeling klinische microbiologie en anti-
microbiele therapie van de Erasmus Universiteit. 
In zijn huidige functie houdt de schrijver zich bezig met 
een onderzoek naar de metabole processen bij de ontwikkelings 
cyclus van het intracellulair levende en sexueel overdraag-
bare micro-organisme, Chlamydia trachomatis. 
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NAWOORD 
Aan de tot stand kerning van dit proefschrift hebben velen een 
bijdrage geleverd. Ik wil iedereen van harte bedanken en 
enkelen wil ik met name noemen: 
Herman Degenhart, die het onderzoek op door mij zeer gewaar-
deerde wijze heeft geleid. Door zijn bereidheid op elk uur 
van de dag, welke hypothese (of luchtspiegeling) dan ook ter 
discussie te willen stellen, heb ik, naast biochernie, veel 
van hem kunnen leren. 
Mijn promotor Prof.Dr. H.K.A. Visser, wiens initiatieven er 
toe hebben geleid dat het hier beschreven onderzoek in het 
Sophia Kinderziekenhuis verricht ken worden. De wording van 
het proefschrift is door hem kritisch begeleid. 
Prof. Dr. Ttl. C. Hiilsmann en Prof. Dr. H. J. van der Molen hebben 
als coreferenten waardevolle kritiek geleverd bij de beoor-
deling van het manuscript. 
Vera van Beek, Ad van den Berg, Aart Bongers, Hein Falke, 
Wil Grose, Hannie de Leeuw-Boon, Jos Leferink en Ron Wever 
hebben bijgedragen aan het experirnentele werk. 
Ab Klippel en Wirn Rietveld hielden de gebruikte apparatuur 
in goede con-di-tie. 
De steeds opgewekte heer G.J. Pleysier voorzag ons, samen met 
zijn medewerkers, van schoon glaswerk. 
Drs. J.J. Leroy, hoofd van het lab. van de vleeskeuringsdienst 
te Rotterdam, voorzag ons regelmatig van runderbijnieren. 
De medewerkers van de Audiovisuele Dienst in het Sophia Kinder-
ziekenhuis verzorgden zowel het grafische werk als de omslag. 
Mary Amesz-Heinrich, Gerarda Schouten en Clementine van Thiel 
hebben de manuscripten getypt. 
Janet Manning, Richard Pearse en Tony Price corrigeerden het 
engels. 
Tenslotte wil ik mijn ouders, die mij stimuleerden de schei-
kunde studie aari te vangen en haar te voltooien, van harte 
bedanken. Echter zonder de steun van Zeljka en rnijn schoon-
ouders was dit proefschrift niet tot stand gekomen. 
Voor al deze steun ben ik zeer dankbaar. 
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"Is u Amsterdammer?" vroeg Bavink. 
"Ja, Goddank," zei Japi. 
Nescio. 
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